Page last updated: 2024-08-24

triazoles and l 743,872

triazoles has been researched along with l 743,872 in 352 studies

Research

Studies (352)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (0.85)	18.2507
2000's	178 (50.57)	29.6817
2010's	162 (46.02)	24.3611
2020's	9 (2.56)	2.80

Authors

Authors	Studies
Espinel-Ingroff, A	1
Baquero, F	1
Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ	1
Coco, BJ; Kirkpatrick, WR; Patterson, TF; Perea, S	1
Fothergill, AW; Gonzalez, G; Kirkpatrick, WR; Patterson, TF; Perea, S; Rinaldi, MG	1
Chryssanthou, E; Cuenca-Estrella, M	1
Garbino, J; Hirschel, B	1
Bernal, S; Chávez M, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Ramirez, M; Serrano, Mdel C; Valverde-Conde, A	1
Chan, J	1
Lipp, HP	1
Holzgrabe, U; Schäfer-Korting, M	1
Alangaden, GJ; Chandrasekar, PH; Manavathu, EK	1
Feldmesser, M; Pamer, EG; Van Epps, HL	1
Sutton, DA	1
Ullmann, AJ	1
Girmenia, C; Martino, P	1
Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA	1
Miller, JL; Perfect, JR; Schell, WA; Steinbach, WJ	1
Schäfer-Korting, M	1
Gupta, AK; Tomas, E	1
Giles, SS; Kurtzberg, J; Perfect, JR; Schell, WA; Steinbach, WJ; Trinh, JV	1
Bliss, JM; Gigliotti, F; Wellington, M	1
Sims-McCallum, RP	1
Bilger, K; D'incan, E; Damaj, G; Doglio, MF; Faucher, C; Gastaut, JA; Ivanov, V; Le Brigand, B; Vey, N	1
Martin, PL; Miller, JL; Perfect, JR; Schell, WA; Steinbach, WJ	1
Espinel-Ingroff, A; Holliday, N; Killian, SB; Knapp, CC; Messer, SA; Pfaller, M	1
Cappelli, B; Castagnola, E; Dodero, P; Faraci, M; Machetti, M; Molinari, AC; Morreale, G; Tomà, P	1
Dupont, B	1
Mehta, J; Trifilio, S; Verma, A; Williams, S; Zembower, T	1
Schwartz, S; Thiel, E	1
Höhl, R	1
Blankenship, JR; Heitman, J; Onyewu, C; Perfect, JR; Schell, WA; Steinbach, WJ	1
Rubin, ZA; Somani, J	1
Alaggio, R; Calore, E; Cesaro, S; Cusinato, R; Messina, C; Pillon, M; Toffolutti, T; Zanesco, L	1
Friedrich, W; Gahr, M; Hahn, G; Koch, A; Roesler, J; Rösen-Wolff, A	1
Antoniades, A; Giotakis, J; Imbrios, G; Manesis, EK; Tsiodras, S; Zafiropoulou, R	1
Germaud, P; Morin, O	1
Gil-Lamaignere, C; Müller, FM; Zhu, LP	1
Blin, N; Gaillard, F; Harousseau, JL; Milpied, N; Moreau, P; Morin, O; Morineau, N	1
Kuijper, EJ; Kullberg, BJ; van 't Wout, JW; Verweij, PE	1
Gavaldá, J; Lumbreras, C	1
Klastersky, J	1
Boeckh, M; Carter, RA; Corey, L; Kim, HW; Marr, KA	1
Viscoli, C	1
D'Antonio, D; Di Bonaventura, G; Picciani, C; Piccolomini, R; Spedicato, I	1
Alangaden, GJ; Chandrasekar, PH; Cutright, JL; Ganesan, LT; Manavathu, EK	1
Benjamin, DK; Heitman, J; Miller, JL; Perfect, JR; Schell, WA; Singh, N; Steinbach, WJ	1
Perfect, JR	2
Marr, K	1
Breit, SM; Grand, MG; Hariprasad, SM; Mieler, WF; Mills, MD; Shah, GK	1
Bareau, B; Camus, C; Tattevin, P	1
Danaher, PJ	1
Lowry, CM; Marty, FM	1
Balwierz, W	1
Belohradsky, BH; Führer, M; Graubner, UB; Kammer, B; Moelter, C; Schmid, I; Schuster, F	1
Alcazar-Fuoli, L; Buitrago, MJ; Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL	1
Bailly, E; Bastides, F; Ehrmann, S; Gissot, V; Legras, A; Magro, P; Mercier, E	1
Dinser, R; Grgic, A; Kim, YJ; Pfreundschuh, M; Schubert, J	1
Cesaro, S; Visintin, G	1
Ermert, L; Lohmeyer, J; Lommel, D; Ludwig, M; Schneider, H; Sziegoleit, A; Weidner, W	1
Gil-Lamaignere, C; Hess, R; Heyn, K; Kappe, R; Müller, FM; Salvenmoser, S	1
Christmann, D; Eisenmann, B; Forestier, E; Hansman, Y; Lesens, O; Martinot, M; Remy, V	1
Böhme, A; Haas, A; Maschmeyer, G	1
Steinbach, WJ	2
Kofla, G; Ruhnke, M	1
Coco, BJ; Fothergill, AW; Kirkpatrick, WR; Oliveira, ER; Patterson, TF; Redding, SW	1
Benjamin, DK; Steinbach, WJ; Zaoutis, TE	1
MacCallum, DM; Odds, FC; Whyte, JA	1
Azar, DT; D'Amico, DJ; Durand, ML; Kieval, SJ; Kim, IK; Loewenstein, JI; Lujan, BJ; Martin, SS; Miller, FS; Miller, JW; Tobin, EH	1
Costa-de-Oliveira, S; Espinel-Ingroff, A; Pina-Vaz, C; Rodrigues, AG	1
Bergeron, A; Dromer, F; Ferry, C; Feuilhade, M; Gluckman, E; Hermoso, DG; Lacroix, C; Molina, JM; Pavie, J; Ribaud, P; Robin, M	1
Bauer, M; Graninger, W; Joukhadar, C; Kulemann, V	1
Bonatti, H; Dierich, MP; Freund, M; Gastl, G; Griff, K; Kropshofer, G; Lass-Flörl, C; Mayr, A; Nachbaur, D; Petzer, A	1
Baker, CJ; Pannaraj, PS; Walsh, TJ	1
Colombo, GL; Morlotti, L; Serra, G	1
Bertz, H; Finke, J; Kern, WV; Sander, A; Wagner, D	1
Conte, JV; Dropulic, LK; Girgis, R; Mcdyer, JF; Orens, JB; Shlobin, OA; Yang, SY	1
Barfield, RC; Behm, FG; Burnette, K; Eldridge, P; Hale, GA; Handgretinger, R; Knapp, K	1
Clemons, KV; Espiritu, M; Parmar, R; Stevens, DA	1
Carpenter, J; Howell, A; Hurley, D; Midturi, J; Sierra-Hoffman, M; Winn, R	1
Chang, SC; Chen, YC; Hsieh, SM; Lee, HT; Pan, SC	1
Marik, PE; Raman, T	1
Aguado, JM; Del Busto, R; Fisher, RA; Forrest, G; Houston, S; Husain, S; Klintmalm, GB; Kontoyiannis, DP; Lewis, RE; Limaye, AP; Miller, R; Montoya, JG; Muñoz, P; Patton, P; Pursell, K; Rosso, F; Safdar, N; Singh, N; Wagener, MM	1
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL	1
Casadevall, A; Martinez, LR	1
Castro-Orjales, MJ; Collell-Llach, MD; de la Torre-Fernández, MJ; Díaz-López, MD; León, C; López-Ciudad, V; Pérez de Juan-Romero, MA; Sanz-Rodríguez, C	1
Bosch, M; Cantón, E; de Llanos, R; Jarque, I; Molina, A; Pemán, J; Salavert, M	1
Buitrago, MJ; Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL	1
Brandenburg, VM; Floege, J; Guetgemann, A; Ketteler, M; Riehl, J	1
Cacciapuoti, A; Halpern, J; Loebenberg, D; Mendrick, C; Norris, C; Patel, R	1
Bäsecke, J; Glass, B; Perske, C; Rüchel, R	1
Björkholm, M; Cherif, H; Kalin, M	1
Burhenne, J; Cornely, OA; Elter, T; Fätkenheuer, G; Gossmann, A; Kuchta, J; Riedel, KD; Schröder, U; Seifert, H; Sieniawski, M; Wickenhauser, C	1
Gottfredsson, M; Steingrímsdóttir, H	1
Kadota, J; Tokimatsu, I	1
Bodkin, J; Bubb, WA; Coen, M; Himmelreich, U; Kuchel, PW; Power, D; Sorrell, TC	1
Aperis, G; Mylonakis, E; Spanakis, EK	1
Edwards, JE; Ibrahim, A; Reed, C; Spellberg, B; Walot, I	1
Manfredi, R; Sabbatani, S	1
Chang, SC; Diekema, DJ; Erzsebet, P; Gibbs, DL; Kibbler, C; Mendez, M; Newell, VA; Pfaller, MA	1
Denning, DW; Gardiner, RE; Howard, SJ; Moore, CB; Park, S; Perlin, DS; Webster, I	1
Demchok, JP; Meletiadis, J; O'Shaughnessy, EM; Stergiopoulou, T; Walsh, TJ	1
Denning, DW; Heep, M; Mosquera, J; Schmitt-Hoffmann, A; Sharp, A; Spickermann, J; Warn, PA	1
Patel, R; Piper, KE; Shuford, JA; Steckelberg, JM	1
Araujo, R; Pina-Vaz, C; Rodrigues, AG	1
Campbell, C; Johnson, E; Lamagni, TL; Pezzoli, L	1
Canton, E; Espinel-Ingroff, A; Gibbs, D; Wang, A	1
Benjamin, DK; Cotten, CM; Perfect, JR; Schell, WA; Smith, PB; Steinbach, WJ; Walsh, TJ	1
Del Castillo, A; Díaz, S; Domínguez-Gil, A; García Vargas, M; Martín, I; Sánchez, C	1
Avci, B; Cetinkaya, Z; Ermis, SS; Inan, UU; Kusbeci, T; Ozturk, F; Yavas, G	1
Meletiadis, J; O'Shaughnessy, EM; Peter, J; Stergiopoulou, T; Walsh, TJ	1
Arthington-Skaggs, B; Ellis, D; Espinel-Ingroff, A; Fothergill, A; Gibbs, DL; Iqbal, N; Messer, S; Pfaller, MA; Rinaldi, M; Wang, A	1
Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA	1
Bonatti, H; Lass-Floerl, C; Lechner, M; Lorenz, I; Piza, H; Rieder, J; Rieger, M	1
Aoun, N; Baixench, MT; Bretagne, S; Dannaoui, E; Desnos-Ollivier, M; Garcia-Hermoso, D; Piketty, C; Ramires, S	1
Alonso, N; Bajo, R; Casado, MS; de la Llana, FG; Fajardo, M; Garcia-Dominguez, M; Sanz-Rodriguez, C; Vagace, JM; Zarallo, L	1
Fincher, T; Fulcher, SF	1
Eichhorn, ME; Hartl, WH; Jauch, KW; Joka, M; Küchenhoff, H; Wolf, H	1
Ament, AJ; de Groot, R; Donnelly, JP; Hübben, MW; Severens, JL; van 't Wout, J; Verweij, PE; Warris, A	1
Acharya, NR; Chidambaram, JD; Fothergill, AW; Hong, KC; Lalitha, P; Lietman, TM; Maxey, KJ; McLeod, SD; Prajna, NV; Ruiz, J; Shapiro, BL; Srinivasan, M	1
Alioua, D; Anract, P; Dougados, M; Dupont, B; Guerini, H; Guignard, S; Hubert, D; Paugam, A	1
Bouza, E; Guembe, M; Guinea, J; Peláez, T; Torres-Narbona, M	1
Maida, CM; Milici, ME; Oliveri, S	1
Braverman, RM; Davis, CM; Dishop, MK; Noroski, LM; Paul, ME; Rosenblatt, HM; Sutton, DA	1
Cantón, E; Chirivella, M; Crespo, M; Frasquet, J; Gobernado, M; Ortiz, R; Osseyran, F; Pemán, J; Pérez-Bellés, C; Quesada, A	1
Eschertzhuber, S; Hoefer, D; Hoermann, C; Lass-Florl, C; Velik-Salchner, C	1
Deising, HB; Serfling, A; Wohlrab, J	1
Aydin, S; Ertugrul, B; Gultekin, B; Kir, E; Uyar, G	1
Gubler, C; Imhof, A; Müllhaupt, B; Schneemann, M; Wildi, SM	1
Gleissner, B; Mansmann, V; Schilling, A; Seibold, M	1
Cesur, S; Kaynak, F; Ozçelik, B; Sipahi, B; Sultan, N	1
Beckius, ML; Borra, H; Griffith, ME; Hawley, JS; Hospenthal, DR; McCall, S; Moon, JE; Murray, CK; Ressner, RA; Rivard, RG	1
Caira, M; Fianchi, L; Maviglia, R; Montini, L; Pagano, L; Posteraro, B; Voso, MT	1
Kontoyiannis, D	1
Gahn, B; Gramatzki, M; Repp, R; Schub, N	1
Bergeron, A; de Latour, RP; Devergie, A; Ferry, C; Ghannoum, M; Gluckmana, E; Lacroix, C; Lapalu, J; Madureira, A; Ribaud, P; Robin, M; Rocha, V; Socié, G	1
Stratakos, G; Zakynthinos, S	1
Barchiesi, F; Maida, CM; Milici, ME; Scalise, G; Spreghini, E	1
Carrillo-Muñoz, AJ; Casals, JB; del Valle, O; Estivill, MD; Ezkurra, PA; Giusiano, G; Quindós, G; Santos, P	1
Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA	1
Arthington-Skaggs, BA; Chaturvedi, V; Ghannoum, MA; Holliday, N; Iqbal, NJ; Killian, SB; Knapp, C; Messer, SA; Ostrosky-Zeichner, L; Pfaller, MA; Ramani, R; Rex, JH; Sein, T; Vazquez, JA; Walsh, TJ	1
Bou, G; Fernández, A; Lueiro, F; Velasco, D	1
Chirch, L; Fuhrer, J; Roche, P	1
Can, MF; Cetiner, S; Gorenek, L; Ozerhan, I; Tozkoparan, E; Yagci, G	1
Begueret, H; Beylot-Barry, M; Couprie, B; Domergue, V; Doutre, MS; Huerre, M; Orlandini, V; Tunon de Lara, M	1
Datry, A; Delabesse, E; Dhédin, N; Etienne, A; Gaspar, N; Lmimouni, B; Morel, V; Vernant, JP	1
Alanio, A; Baruchel, A; Brethon, B; de Kerviler, E; Feuilhade de Chauvin, M; Lacroix, C; Leblanc, T; Menotti, J	1
Chu, CC; Hsueh, PR; Ruan, SY	1
Mavinkurve-Groothuis, AM; van Die, LE; van't Hek, LG; Verweij, PE; Warris, A; Zwitserloot, AM	1
Lahat, Y; Sandovsky-Losica, H; Segal, E; Shwartzman, R	1
Kulpraneet, M; Panichchob, P; Prayongratana, K; Tantisiriwat, W	1
Benesch, M; Dornbusch, HJ; Lackner, H; Schwinger, W; Sovinz, P; Strenger, V; Urban, C	1
Ayala, J; Elizondo, M; González, GM	1
Mircus, G; Osherov, N; Shadkchan, Y; Shalit, I	1
Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, WJ; Smith, RP	1
Gafter-Gvili, A; Goldberg, E; Leibovici, L; Paul, M; Vidal, L	1
Bouadma, L; Da Silva, D; Massias, L; Nataf, P; Papy, E; Ruiz, S; Wolff, M	1
Alves, AF; Anjos, J; de Hoog, GS; Estevão, H; Faria, E; Gonçalves, T; Hipolito, E; Morais, PV	1
Jones, B; Lang, S; McCulloch, E; Mowat, E; Ramage, G; Williams, C	1
Brown, TA; Grooters, AM; Hosgood, GL	1
Niki, Y	1
Tu, EY	1
Enache-Angoulvant, A; Girard, A; Hennequin, C; Poirot, JL	1
Annaert, P; Hermans, G; Meersseman, P; Meersseman, W; Spriet, I; Verbesselt, R; Willems, L	1
Chemaissani, A; Ernestus, K; Kamp, M; Knüttgen, D; Matten, J; Sakka, SG; Ströhlein, M; Wappler, F	1
Fanci, R	1
Graninger, W; Kratzer, C; Lassnigg, A; Presterl, E; Tobudic, S	2
Ayats, J; Fernández, N; Gasch, O; Santin, M	1
Aşik, G; Ayçiçek, A; Cetinkaya, Z; Kenar, F; Kiraz, N; Kiyici, H	1
Baggen, L; Chisholm, J; Sharland, M; Thomas, L	1
Pérez, P; Piñar, D; Quiles, JA; Reus, S	1
Castel, V; Gonzalez-Esteban, J; Madero, L; Sanchez de Toledo, J; Sanz-Rodriguez, C; Sevilla, J	1
Berger, N; Bonatti, H; Geltner, C; Grif, K; Lass-Flörl, C; Lechner, M; Margreiter, R; Stelzmueller, I	1
Angerer, K; Bonatti, H; Geltner, C; Lass-Floerl, C; Lechner, M; Schmid, T; Singh, N; Singh, R; Stelzmueller, I	1
Barozzi, P; Forghieri, F; Luppi, M; Messino, M; Morselli, M; Pecorari, M; Potenza, L; Rossi, G; Rumpianesi, F; Torelli, G; Vallerini, D	1
Brilhante, RS; Cordeiro, Rde A; de Camargo, ZP; de Lima, RA; Medrano, DJ; Monteiro, AJ; Rocha, MF; Sidrim, JJ; Tavares, JL	1
Eberhardt, R; Ebinger, D; Eckerle, I; Eisenbach, C; Gotthardt, D; Junghanss, T; Schnabel, PA; Stremmel, W	1
Delaere, L; Lagrou, K; Maertens, J; Peetermans, WE; Spriet, I; Willems, L	1
Amorim, CS; Briones, MR; Colombo, AL; Gonçalves, SS; Melo, AS; Nucci, M; Padovan, AC	1
Groll, AH; Tragiannidis, A	1
Bonnal, C; Bouges-Michel, C; Bretagne, S; Chochillon, C; Dannaoui, E; Datry, A; Develoux, M; Dromer, F; Matheron, J; Paugam, A	1
Ali, R; Altundal, Y; Ener, B; Hakyemez, B; Kocaeli, H; Ozçelik, T; Ozkalemkaş, F; Ozkocaman, V; Tunali, A	1
Boikov, D; Nagappan, V; Vazquez, JA	1
Aloisi, T; Aversa, F; Bonini, A; Caira, M; Candoni, A; Caramatti, C; Cattaneo, C; Chierichini, A; de Waure, C; Fadda, RM; Fanci, R; Ferrara, F; Fianchi, L; Invernizzi, R; Leone, G; Luppi, M; Martino, B; Melillo, L; Mitra, ME; Nosari, A; Offidani, M; Pagano, L; Pastore, D; Picardi, M; Potenza, L; Riva, M; Rossini, F; Specchia, G; Stanzani, M; Vacca, A	1
Capote, M; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rojas, R; Sánchez-García, J; Serrano, J; Tabares, S; Torres, A	1
Al-Abdely, HM; Al-Tawfiq, JA	1
Akin, M; Ay, Y; Balkan, C; Karapinar, B; Kavakli, K; Yilmaz, D	1
Christen, S; Egger, SS; Gratwohl, A; Haschke, M; Krähenbühl, S; Leu, C; Meier, S	1
Alvarez, M; Attal, M; Cassaing, S; Chabrol, A; Cuzin, L; Giron, J; Huguet, F; Linas, MD; Récher, C; Tetu, L; Verdeil, X	1
Cornely, OA; Rüping, MJ; Vehreschild, JJ	1
Bakker-Woudenberg, IA; Tavakol, M; van de Sande, WW; van Vianen, W	1
Badali, H; De Hoog, GS; Illnait-Zaragozi, MT; Meis, JF; Najafzadeh, MJ	1
Corradini, N; Dannaoui, E; Gay-Andrieu, F; Hoinard, D; Lortholary, O; Méchinaud, F; Roux, BG	1
Georgiadou, E; Roilides, E; Simitsopoulou, M; Walsh, TJ	1
Begué, D; Billaud, E; Boussaud, V; Caruba, T; Guillemain, R; Korb, V; Prognon, P; Sabatier, B; Thomas, A	1
Dag, I; Kasifoglu, N; Kiraz, N; Kiremitci, A; Oz, Y; Yamac, M	1
Li, H; Lu, Q; Wan, Z; Zhang, J	1
Bouchara, JP; Danner-Boucher, I; Despins, P; Gay-Andrieu, F; Haloun, A; Horeau-Langlard, D; Jossic, F; Le Pape, P; Miegeville, M; Morio, F; Nourry, L; Pattier, S; Talarmin, JP; Treilhaud, M	1
Jensen, SG; Nielsen, TL	1
Corey, M	1
Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA	1
Beresford, E; Krishna, G; Ma, L; Medlock, M; Noren, C; Power, E; Vickery, D; Yu, X	1
Kim, A; Kuti, JL; Nicolau, DP	1
Berrak, SG; Cakir, E; Cakir, FB; Canpolat, C; Dagli, E; Karakoc, F; Uyan, ZS	1
Andreesen, R; Beier, F; Hildebrandt, GC; Holler, E; Holzmann, T; Kittan, N; Schardt, K	1
Cisneros-Lanuza, A; Díaz-Llopis, M; Duch-Samper, A; Hurtado-Sarrió, M; Peman-Garcíia, J; Vazquez-Polo, A	1
Dalpke, A; Müller, FM; Salvenmoser, S; Seidler, MJ	1
Aversa, F; Caira, M; Candoni, A; Leone, G; Luppi, M; Martino, B; Nosari, A; Offidani, M; Pagano, L; Specchia, G; Tosti, ME; Valentini, CG	1
Cordonnier, C; Cornely, OA; Flückiger, U; Frêre, P; Gachot, B; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Maertens, J; Marchetti, O; Ribaud, P; Thiebaut, A	1
Belda, S; Cremades, R; Lopez, P; Rodriguez, JC; Royo, G; Ruiz-Garcia, M; Soler, L	1
Ehlert, K; Fegeler, W; Groll, AH; Kerl, K; Koch, B; Rossig, C	1
Atalay, H; Erekul, S; Nar, A; Ozbek, O; Solak, Y; Turk, S; Turkmen, K	1
Cai, B; Chen, H; Li, G; Li, H; Liu, W; You, C	1
Guarro, J; Mayayo, E; Pastor, FJ; Pujol, I; Ruíz-Cendoya, M; Sutton, DA	1
Bello, I; Golmia, R; Hamerschlak, N; Marra, A; Osawa, A; Scheinberg, M	1
Bille, J; Calandra, T; Decosterd, LA; Marchetti, O; Mercier, T; Pesse, B; Rochat, B; Tissot, F; Widmer, N; Zanolari, B	1
Huang, Y; Li, HY; Liu, L; Wang, GY; Xia, ZF; Zhang, JR; Zhu, SH	1
Chen, DM; Guo, LN; Liu, Y; Lü, HX; Shi, JY; Shi, Y; Wang, H; Xi, LY; Xu, YC; Zhao, WS; Zhou, X	1
Coorevits, L; Jeurissen, A; Lagrou, K; Schuermans, C; Surmont, I; van Bergen, M; Verhaegen, J	1
Falcone, M; Massetti, AP; Russo, A; Venditti, M; Vullo, V	1
Ayuk, FA; Dahlke, J; Kröger, N; Lellek, H; Waldenmaier, D; Wolschke, C; Zander, AR	1
Ko, KS; Lee, JY; Peck, KR; Song, JH	1
Abbes, S; Ayadi, A; Ben Jemaa, M; Bouaziz, M; Cheikhrouhou, F; Chelly, H; Hammami, B; Khaled, S; Makni, F; Néji, S; Sellami, A; Sellami, H	1
Kuithan, F; Scheer, F; Wiggermann, P	1
Blanche, S; Bougnoux, ME; Catherinot, E; Coignard, H; Debourgogne, A; Garcia-Hermoso, D; Hassouni, N; Lecuit, M; Lortholary, O; Machouart, M; Rivier, A; Salmon, A	1
Andes, D; Bastulli, C; Chaturvedi, V; Diekema, DJ; Ghannoum, MA; Iqbal, N; Knapp, C; Lockhart, SR; Marchillo, K; Messer, S; Ostrosky-Zeichner, L; Paetznick, VL; Pfaller, MA; Ramani, R; Rodriguez, J; Sein, T; Walsh, TJ; Welshenbaugh, AR	1
Dag, I; Kiraz, N; Oz, Y	2
Öncü, S	1
Gurgle, HE; Oinonen, MJ; Pakyz, AL	1
Antachopoulos, C; Chatzimoschou, A; Georgiadou, E; Katragkou, A; Roilides, E; Simitsopoulou, M; Walsh, TJ	1
Ananda-Rajah, MR; Cheng, A; Dooley, M; Morrissey, CO; Neville, AM; Slavin, M; Spelman, T	1
Cheah, FK; Chlebicka, NL; Goh, YT; Kurup, A; Lin, RT; Low, JG; Tan, BH; Wong, GC	1
Ruiz-Camps, I	1
Diekema, DJ; Ledeboer, NA; Peterson, JF; Pfaller, MA; Riebe, KM; Rinaldi, MG	1
Karthaus, M	1
Kong, DC; Leung, L; Neoh, CF; Stewart, K; Vajpayee, RB	1
Angoulvant, A; Epaud, R; Le Pointe, HD; Levine, E; Petit, A	1
Clemons, KV; Schwartz, JA; Stevens, DA	2
Garcia-Hermoso, D; Gay-Andrieu, F; Haloun, A; Le Pape, P; Leclair, F; Lepoivre, T; Miegeville, M; Miossec, C; Morio, F; Treilhaud, M	1
Ilkit, M; Kiraz, N; Oz, Y; Ozdemir, HG	1
Bhagwat, K; Brooks, M; Eisen, D; Royse, A; Royse, C; Sparks, P	1
Castanheira, M; Hata, K; Jones, RN; Messer, SA; Moet, GJ; Pfaller, MA	1
Barbui, A; Busca, A; De Rosa, FG; Falda, M; Limerutti, G; Locatelli, F	1
Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY	1
Lingegowda, PB; Tan, AL; Tan, BH; Tan, CK	1
Björkholm, M; Celsing, F; Grane, P; Kalin, M	1
Al-Badriyeh, D; Kong, DC; Liew, D; Stewart, K	1
Banerjee, R; Dhiman, N; Henry, NK; Huskins, WC; Joshi, AY; Santillan Salas, CF; Wengenack, NL	1
Castanheira, M; Duncanson, F; Jones, RN; Messer, SA; Moet, GJ; Pfaller, MA	1
Bassetti, M; Molinari, MP; Mussap, M; Nicco, E; Taramasso, L; Viscoli, C	1
Jones, B; Kirkpatrick, WR; Lappin, DF; McCulloch, E; Patterson, TF; Rajendran, R; Ramage, G; Shrief, R; Warn, P; Williams, C	1
Labbé, AC; Laverdière, M; Levallois, J; Nadeau-Fredette, AC; Ouimet, D; Vallée, M	1
Al-Saigh, R; Meletiadis, J; Roilides, E; Velegraki, A; Walsh, TJ; Zerva, L	1
Castanheira, M; Diekema, DJ; Duncanson, FP; Guarro, J; Jones, RN; Pfaller, MA	1
Bouza, E; Giannella, M; Guinea, J; Klaassen, CH; Muñoz, P; Peláez, T; Valerio, M	1
Campos-Herrero, MI; Horcajada, I; Medina-Rivero, F; Tandón, L	1
Shen, YF; Sun, HL; Zhou, X	1
Arancia, S; Arruda, DC; Ciociola, T; Conti, S; D'Adda, T; De Bernardis, F; Gabrielli, E; Galati, S; Magliani, W; Pericolini, E; Pertinhez, TA; Pinto, MR; Polonelli, L; Spisni, A; Travassos, LR; Vecchiarelli, A; Zanello, PP	1
Bedin, M; D'Angelo, M; Gion, M; Grandesso, S; Mazzuccato, S; Sapino, B; Solinas, M	1
Alves, SH; Antunes, MS; Bandeira, LA; Denardi, LB; Mario, DA; Santurio, JM; Severo, LC	1
Egerer, G	1
Bai, C; Chen, B; Huang, HD; Huang, Y; Li, Q; Wang, Q; Wu, N; Yao, XP	1
Baghaei, P; Droudinia, A; Javanmard, P; Mansouri, D; Marjani, M; Najafizadeh, K; Sarrafzadeh, SA; Soraghi, A; Tabarsi, P; Zandian, P	1
Chen, TC; Chen, YC; Chen, YH; Lu, PL	1
Chen, Z; Wei, J; Yang, Q	1
Andes, DR; Baddley, JW; Boeckh, M; Brizendine, KD; Chiller, T; Ito, JI; Kauffman, CA; Kontoyiannis, DP; Lyon, GM; Marr, KA; Oster, RA; Pappas, PG; Patterson, TF; Schuster, MG	1
Brilhante, RS; Caetano, ÉP; Camargo, ZP; Castelo-Branco, DS; Cordeiro, RA; Fechine, MA; Lima, RA; Mesquita, JR; Monteiro, AJ; Pereira, JF; Rocha, MF; Sidrim, JJ	1
Dag, I; Kiraz, N; Kiremitci, A; Metintas, S; Oz, Y	1
Maack, KH; Tarp, B	1
Ahmed, S; de Hoog, GS; Feng, P; Klaassen, CH; Lai, W; Lu, C; Meis, JF; Najafzadeh, MJ; Sun, J; Xi, L	1
Berghs, HAM; Carvalho, LR; Kacew, S; Martins, MA; Melhem, MSC; Mendes, RP; Moris, DV; Pimenta-Rodrigues, MV; Souza, LR; Szeszs, MW	1
Curtis, LT	1
de Souza Bonfim-Mendonça, P; Fiorini, A; Godoy, JS; Nakamura, SS; Pieralisi, N; Shinobu-Mesquita, C; Svidzinski, TI; Yamada, SS	1
Buendía, B; Cuenca-Estrella, M; De La Camara, R; Mellado, E; Rodriguez-Tudela, JL	1
Chen, W; Li, L; Li, R; Liu, W; Sun, Y; Wan, Z	1
Chauhan, NM; Karuppayil, SM; Raut, JS; Shinde, RB	1
Denes, E; Dupon, M; Fiorenza, F; Megherbi, M; Saint-Marcoux, F; Weinbreck, P	1
Brisou, P; Darles, C; Gaillard, T; Pons, S; Roméo, E	1
Buer, J; Dittmer, S; Hamprecht, A; Lackner, M; Rath, PM; Schemuth, H; Sedlacek, L; Steinmann, E; Steinmann, J	1
Brilhante, RS; Caetano, EP; Camargo, ZP; Castelo Branco, DS; Cordeiro, RA; Fechine, MA; Lima, DT; Lima, RA; Marques, FJ; Mesquita, JR; Monteiro, AJ; Rocha, MF; Sidrim, JJ	1
Yoshida, M	1
Shi, Y; Sun, HM; Xu, XY; Zhao, BL	1
Badali, H; Curfs-Breuker, I; de Hoog, GS; Deng, S; Liao, W; Meis, JF; Najafzadeh, MJ; Pan, B; Yang, L	1
Jones, B; Jose, A; Lappin, DF; Ramage, G; Sherry, L; Williams, C	1
Levy, ER; McCarty, JM; Shane, AL; Weintrub, PS	1
Galgiani, JN	1
Averette, AF; Chen, YL; Heitman, J; Lehman, VN; Perfect, JR	1
Li, R; Yu, J; Zhang, S	1
Arıkan Akdağlı, S; Aydeniz Ozansoy, F; Dursunoğlu, N; Ergin, C; Kutlu, M; Sarı, I; Sarıbaş, Z	1
Hatipoglu, H; Hatipoglu, N	1
Andes, DR; Lepak, AJ; Marchillo, K; VanHecker, J	1
Aline-Fardin, A; Buot, G; Dannaoui, E; Degulys, A; Guitard, J; Hennequin, C; Lapusan, S; Marie, JP; Rio, B	1
Boral, OB; Cağatay, P; Keçeli, SA; Sonmez, N; Tamer, GS; Willke, A	1
Curfs-Breuker, I; de Hoog, GS; Feng, P; Meis, JF; Najafzadeh, MJ; Rezaei-Matehkolaei, A; Saradeghi Keisari, M; Shamsian, SA; Vicente, VA	1
Bierings, MB; Boelens, JJ; Gerhardt, CE; Hol, JA; Lindemans, CA; Versluys, AB; Wildt de, A; Wolfs, TF	1
Atalay, MA; Copur Çiçek, A; Kasap Tekinşen, FF; Kaynar, L; Koç, AN; Sav, H	1
Balci, I; Eksi, F; Gayyurhan, ED	1
Chen, F; Shi, Y; Su, X; Sun, WK; Xu, XY; Zhang, M	1
Ascioglu, S; Chan, KA	1
Kunicka-Styczyńska, A; Maroszyńska, I; Maroszyńska, M; Rajkowska, K	1
Aslan, SO; Dizbay, M; Fidan, I; Kalkanci, A; Ogan, MC; Sahin, N; Yesilyurt, E	1
Jackson, TL; Rodrigues, IA	1
Bandeira, TJPG; Brilhante, RSN; Cordeiro, RA; Macedo, RB; Marques, FJF; Moreira, JLB; Rocha, MFG; Sidrim, JJC; Teixeira, CEC	1
Berg, T; Brandmaier, P; Jonas, S; Lübbert, C; Mohr, FW; Pfeiffer, D; Rodloff, A; Schmelzle, M; Schubert, S; Wiltberger, G	1
Albert, ND; Kontoyiannis, DP; Lewis, RE	1
Mavridou, E; Meletiadis, J; Mouton, JW; Rijs, A; Verweij, PE	1
Badali, H; de Hoog, GS; Mashedi, O; Meis, JF; Mohammadi, R	1
Li, R; Wan, Z; Yao, L; Yu, J	1
Bulanda, M; Jagielski, T; Skóra, M	1
Chowdhary, A; Curfs-Breuker, I; de Hoog, GS; Hagen, F; Madrid, H; Meis, JF	1
Arilla, MJ; Boluda, B; Calvillo, P; Cano, I; Carpio, N; Jarque, I; Lancharro, A; López-Chuliá, F; Lorenzo, I; Martínez, J; Martínez-Cuadrón, D; Montesinos, P; Navarro, I; Pemán, J; Rodríguez-Veiga, R; Salavert, M; Sanz, GF; Sanz, J; Sanz, MA	1
Badali, H; Chowdhary, A; de Hoog, GS; Fakhim, H; Khodavaisy, S; Meis, JF	1
Gökbolat, E; Ilkit, M; Kiraz, N; Öz, Y; Özdemir, HG; Seyedmousavi, S	1
Badali, H; Dolatabadi, S; Fakhim, H; Mirhendi, H; Nabili, M; Poorzad, N; Vaezi, A; Zarei, F	1
Hall, RG; Payne, KD	1
Aala, F; Amirizad, K; Aslani, N; Badali, H; Hashemi, SJ; Khodavaisy, S; Nazeri, M; Nouripour-Sisakht, S; Rezaie, S; Sorkherizi, MS	1
Ding, X; Gao, L; Liu, Z; Sun, Y; Wu, Q; Zeng, T	1
Lanternier, FL; Lortholary, O; Pilmis, B	1
Arslan, U; Dagi, HT; Findik, D; Senkeles, C	1
Legendre, DP; Muzny, CA; Riley, TT; Swiatlo, E	1
Chung, SJ; Hwang, WY; Tan, AL; Tan, BH; Tan, TT; Thien, SY	1
Ahmed, SA; Behrens-Baumann, W; de Hoog, GS; Harak, H; Hofmüller, W; Seibold, M; Tammer, I; van Diepeningen, AD	1
Banjara, N; Florescu, DF; Gomes-Neto, JC; Hallen-Adams, HE; Iwen, PC; Mercer, DF; Suhr, MJ	1
Birch, M; Law, D; Wiederhold, NP	1
Arthur, I; Baird, R; Bak, N; Blyth, C; Botes, J; Chapman, B; Chen, S; Cheong, E; Cooley, L; George, CR; Goeman, E; Hajkowicz, K; Halliday, C; Heath, CH; Hofmeyr, A; Kalukottege, P; Keighley, C; Kennedy, K; Kesson, A; Kidd, S; Korman, TM; Leung, M; Liu, E; Macesic, N; Marriott, D; McMullan, B; Morrissey, CO; Pendle, S; Robson, J; Slavin, M; Sorrell, TC; Underwood, N; van Hal, S; Weeks, K	1
Bader, O; Baretton, G; Buchheidt, D; Geibel, S; Groß, U; Jacobs, E; Ostrosky-Zeichner, L; Rößler, S; Sommer, U; Spiess, B; Stölzel, F	1
Badali, H; Chowdhary, A; Dannaoui, E; Fakhim, H; Meis, JF; Prakash, A; Vaezi, A	1
Badali, H; Badiee, P; Boekhout, T; Diba, K; Hossaini Nasab, A; Jafarian, H; Mirhendi, H; Moghadam, AG; Mohammadi, R; Najafzadeh, MJ; Shamsizadeh, A; Soltani, J	1
Ahangarkani, F; Aslani, N; Badali, H; Boekhout, T; Hagen, F; Kolecka, A; Meis, JF; Meyabadi, MF; Shokohi, T	1
El-Najjar, N; Gessner, A; Hösl, J	1
Andersen, LO; Arendrup, MC; Hare, RK; Irga-Jaworska, N; Jaworski, R; Jensen, HE; Malecka, A; Nielsen, HV; Pomorska, A; Radon-Proskura, J	1
Andes, D	1
Chetchotisakd, P; Croos-Dabrera, R; De Waele, J; Engelhardt, M; Fredericks, C; Herbrecht, R; Jaruratanasirikul, S; Kovanda, L; Kullberg, BJ; Lademacher, C; Ostrosky-Zeichner, L; Pappas, PG; Rahav, G; Rotstein, C; Sobel, JD; Thompson, GR; Van Wijngaerden, E; Vazquez, J; Viscoli, C	1
Lehrnbecher, T; Schmidt, S; Schubert, R; Tramsen, L	1
Eraso, E; Gil-Alonso, S; Jauregizar, N; Marcos-Arias, C; Mateo, E; Quindós, G; Sevillano, E	1
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E	1
Erbaş, G; Kalkanci, A; Köktürk, N; Özkurt, ZN; Pepeler, MS; Tunçcan, ÖG; Yegin, ZA; Yildirim, Z; Yildiz, Ş	1
Gharaghani, M; Taghipour, S; Zarei Mahmoudabadi, A	1
Alexander, S; Chen, L; Dang, H; Dvorak, CC; Esbenshade, AJ; Fisher, BT; Nieder, ML; Skeens, M; Steinbach, WJ; Sung, L; Villaluna, D; Zaoutis, TE	1
Borman, AM; Forgács, L; Jakab, Á; Kovács, R; Majoros, L; Nagy, F; Nyikos, F; Tóth, Z	1
Abdollahi, A; Ahmadikia, K; Alijani, N; Barac, A; Jafari, R; Khodavaisy, S; Mehrparvar, G; Pakdel, F; Rajaeih, S; Rezaie, Y; Salehi, M; Tabari, A	1
Amanati, A; Badiee, P; Ghasemi, F; Haghpanah, S; Hamzavi, SS; Jafarian, H; Nematolahi, S	1
Arendrup, M; Botterel, F; Bourgeois, N; Bouteille, B; Canton, E; Cassaing, S; Dannaoui, E; Dehais, M; Delhaes, L; Dupont, D; Espinel-Ingroff, A; Fekkar, A; Forastiero, A; Fuller, J; Garcia, J; Garcia-Effron, G; Gonzalez, GM; Govender, NP; Guegan, H; Guinea, J; Houzé, S; Lackner, M; Lass-Flörl, C; Magobo, R; Pelaez, T; Sasso, M; Turnidge, J	1
Dong, Y; Liu, Z; Wang, Y; Wang, YF; Xie, J; Yang, Q; Zhang, K	1
Hakki, M; Lewis, JS; Thompson, GR; Wiederhold, NP	1
Amin Shahidi, M; Badiee, P; Ghasemi, F; Hashemi, J; Jafarian, H; Mohammadi, R; Najafzadeh, MJ; Shokohi, T	1

Reviews

58 review(s) available for triazoles and l 743,872

Article	Year
[Clinical development of antimycotics. Medical challenges]. Pharmazie in unserer Zeit, 2003, Volume: 32, Issue:2 Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Excipients; Fungi; Humans; Itraconazole; Lipopeptides; Liposomes; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Voriconazole	2003
[A silver lining on the horizon: new antimycotics]. Pharmazie in unserer Zeit, 2003, Volume: 32, Issue:2 Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Echinocandins; Fungi; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2003
Laboratory evaluation of new antifungal agents against rare and refractory mycoses. Current opinion in infectious diseases, 2002, Volume: 15, Issue:6 Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Echinocandins; Fungi; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole	2002
Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole. Current medical research and opinion, 2003, Volume: 19, Issue:4 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Drug Interactions; Echinocandins; Humans; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2003
New antifungal drugs and new clinical trials: interpreting results may be difficult. Current opinion in oncology, 2003, Volume: 15, Issue:4 Topics: Animals; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Data Interpretation, Statistical; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2003
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide. Journal of clinical microbiology, 2003, Volume: 41, Issue:8 Topics: Administration, Topical; Anti-Bacterial Agents; Antifungal Agents; Biguanides; Caspofungin; Child, Preschool; Disinfectants; Echinocandins; Humans; Lipopeptides; Magnetic Resonance Imaging; Male; Mucormycosis; Osteomyelitis; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole	2003
[New systemic antifungal drugs: mechanisms of action, drug interactions and side effects]. Mycoses, 2003, Volume: 46 Suppl 1 Topics: Anti-Bacterial Agents; Antifungal Agents; Azoles; Caspofungin; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Fungi; Glucosyltransferases; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2003
New antifungal agents. Dermatologic clinics, 2003, Volume: 21, Issue:3 Topics: Administration, Oral; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Drug Approval; Echinocandins; Humans; Lipopeptides; Macrolides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole	2003
Antifungal pharmacotherapy for neonatal candidiasis. Seminars in perinatology, 2003, Volume: 27, Issue:5 Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2003
Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients. The Journal of infection, 2004, Volume: 48, Issue:1 Topics: Antifungal Agents; Caspofungin; Child; Echinocandins; Fatal Outcome; Humans; Immunocompromised Host; Lipopeptides; Male; Mitosporic Fungi; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole	2004
[New antifungal agents: voriconazole and caspofungin]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2003, Volume: 10 Suppl 5 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Drug Interactions; Echinocandins; Humans; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2003
CNS-aspergillosis: are there new treatment options? Mycoses, 2003, Volume: 46 Suppl 2 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blood-Brain Barrier; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Male; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2003
[New therapeutical options for pulmonary fungal infections in non-neutropenic ICU-patients]. Mycoses, 2003, Volume: 46 Suppl 2 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Fungi; Humans; Intensive Care Units; Lipopeptides; Lung Diseases, Fungal; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole	2003
New options for the treatment of invasive fungal infections. Seminars in oncology, 2004, Volume: 31, Issue:2 Suppl 4 Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycetoma; Mycoses; Neoplasms; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole	2004
[New antifungal agents and bronchopulmonary mycoses]. Revue de pneumologie clinique, 2004, Volume: 60, Issue:3 Topics: Antifungal Agents; Caspofungin; Drug Costs; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lung Diseases, Fungal; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2004
[New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin]. Nederlands tijdschrift voor geneeskunde, 2004, Aug-21, Volume: 148, Issue:34 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole	2004
[Invasive aspergillosis: clinical manifestations and treatment]. Revista iberoamericana de micologia, 2003, Volume: 20, Issue:3 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Caspofungin; Dermatomycoses; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Immunologic Factors; Itraconazole; Lipopeptides; Neuroaspergillosis; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Respiratory Tract Infections; Triazoles; Voriconazole	2003
Use of newer antifungal therapies in clinical practice: what do the data tell us? Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis	2004
Combination antifungal therapy: where are we now, and where are we going? Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Caspofungin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole	2004
Antifungal resistance: the clinical front. Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:14 Suppl 1 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Health Status; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Risk Factors; Thiazoles; Treatment Outcome; Triazoles; United States; Voriconazole	2004
Systemic aspergillosis with predominant genitourinary manifestations in an immunocompetent man: what we can learn from a disastrous follow-up. Infection, 2005, Volume: 33, Issue:2 Topics: Abscess; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Kidney Diseases; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Peptides, Cyclic; Prostatic Diseases; Pyrimidines; Retroperitoneal Space; Triazoles; Voriconazole	2005
A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Volume: 24, Issue:5 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Echinocandins; Female; Heart Transplantation; Humans; Lipopeptides; Mediastinitis; Middle Aged; Peptides, Cyclic; Pyrimidines; Surgical Wound Infection; Triazoles; Voriconazole	2005
[Update on therapy of invasive mycoses in hematology and oncology]. Deutsche medizinische Wochenschrift (1946), 2005, Jun-03, Volume: 130, Issue:22 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Drug Combinations; Echinocandins; Hematologic Neoplasms; Humans; Itraconazole; Lipopeptides; Liposomes; Mycoses; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Risk Factors; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis	2005
Antifungal agents in children. Pediatric clinics of North America, 2005, Volume: 52, Issue:3 Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole	2005
Voriconazole: review of a broad spectrum triazole antifungal agent. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:7 Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Cryptococcosis; Cyclic N-Oxides; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Injections, Intravenous; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole	2005
Antifungal treatment in pediatric patients. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2005, Volume: 8, Issue:4 Topics: Adolescent; Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungal Proteins; Humans; Infant; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Triazoles	2005
Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis. Journal of clinical microbiology, 2005, Volume: 43, Issue:9 Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Chemoprevention; Drug Resistance, Fungal; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Peptides, Cyclic; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole	2005
Combination antifungal therapy for invasive aspergillosis: utilizing new targeting strategies. Current drug targets. Infectious disorders, 2005, Volume: 5, Issue:3 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2005
Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients. Pharmacology, 2005, Volume: 75, Issue:4 Topics: Anti-Bacterial Agents; Anticonvulsants; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Cross Infection; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Monitoring; Echinocandins; Food-Drug Interactions; Humans; Immunocompromised Host; Intensive Care Units; Lipopeptides; Liver; Mycoses; Peptides, Cyclic; Polypharmacy; Pyrimidines; Reverse Transcriptase Inhibitors; Triazoles; Voriconazole	2005
Fungal infections in bone marrow transplant recipients. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:3 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Caspofungin; Drug Administration Schedule; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Postoperative Complications; Premedication; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole	2006
[Efficacies and clinical roles of new antifungal agents]. Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 2006, Volume: 47, Issue:3 Topics: Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2006
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Oct-15, Volume: 43, Issue:8 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Echinocandins; Fever; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2006
[Native valve Aspergillus fumigatus endocarditis with blood culture positive and negative for galactomannan antigen. Case report and literature review]. Revista iberoamericana de micologia, 2007, Volume: 24, Issue:2 Topics: Amaurosis Fugax; Aneurysm, Infected; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Biomarkers; Caspofungin; Combined Modality Therapy; Echinocandins; Endocarditis; False Negative Reactions; Fatal Outcome; Fungemia; Galactose; Heart Valve Prosthesis Implantation; Humans; Infarction; Kidney; Lipopeptides; Male; Mannans; Mesenteric Arteries; Mesenteric Vascular Occlusion; Middle Aged; Mitral Valve; Peptides, Cyclic; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Renal Artery; Triazoles; Voriconazole	2007
[Addressing the "Hot Spots" in the management of invasive aspergillosis]. Medecine et maladies infectieuses, 2007, Volume: 37 Suppl 2 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Disease Management; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Treatment Outcome; Triazoles	2007
Invasive pulmonary aspergillosis after liver transplantation: rapid and complete response to combined and sequential antifungal therapy. Surgical infections, 2008, Volume: 9, Issue:1 Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Immunosuppression Therapy; Lipopeptides; Liver Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Radiography, Thoracic; Tomography, Emission-Computed; Triazoles; Voriconazole	2008
Acute monoblastic leukemia with t(10;11)(p12;q23) presenting with pulmonary involvement: a case report and literature review. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2008, Volume: 91, Issue:4 Topics: Adult; Antibiotics, Antineoplastic; Antifungal Agents; Antimetabolites, Antineoplastic; Aspergillosis, Allergic Bronchopulmonary; Bronchoalveolar Lavage; Caspofungin; Cytarabine; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Monocytic, Acute; Lipopeptides; Lung Neoplasms; Male; Pyrimidines; Thailand; Triazoles; Voriconazole	2008
Treatment of invasive candidal infections: systematic review and meta-analysis. Mayo Clinic proceedings, 2008, Volume: 83, Issue:9 Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Confidence Intervals; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Odds Ratio; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2008
[Trends in development of new antifungal agents in Japan]. Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:12 Topics: Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Discovery; Echinocandins; Humans; Japan; Lipopeptides; Mycoses; Triazoles	2008
Diagnosis and treatment of aspergillosis in children. Expert review of anti-infective therapy, 2009, Volume: 7, Issue:4 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Echinocandins; Fungal Vaccines; Genomics; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Pyrimidines; Risk Factors; Triazoles; Voriconazole	2009
Invasive Aspergillus fumigatus infection after Plasmodium falciparum malaria in an immuno-competent host: case report and review of literature. Malaria journal, 2009, Jul-20, Volume: 8 Topics: Antifungal Agents; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Malaria, Falciparum; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole	2009
Hyperbaric oxygen therapy and other adjunctive treatments for zygomycosis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2009, Volume: 15 Suppl 5 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Debridement; Echinocandins; Humans; Hyperbaric Oxygenation; Immunologic Factors; Lipopeptides; Oxygen; Triazoles; Zygomycosis	2009
Primary antifungal prophylaxis in acute myeloblastic leukemia and myelodysplastic syndrome--still an open question? Leukemia & lymphoma, 2010, Volume: 51, Issue:1 Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Resistance, Fungal; Echinocandins; Fever; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Medical Oncology; Mycoses; Myelodysplastic Syndromes; Triazoles	2010
Modern antifungal therapy for neutropenic fever. Current hematologic malignancy reports, 2006, Volume: 1, Issue:2 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fever; Humans; Immunocompromised Host; Kidney Diseases; Lipopeptides; Liposomes; Liver Diseases; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole	2006
Traditional and emerging antifungal therapies. Proceedings of the American Thoracic Society, 2010, Volume: 7, Issue:3 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole	2010
Aspergillus fumigatus joint infection: a review. Seminars in arthritis and rheumatism, 2011, Volume: 40, Issue:6 Topics: Antifungal Agents; Arthritis, Infectious; Aspergillosis; Aspergillus fumigatus; Caspofungin; Combined Modality Therapy; Drainage; Echinocandins; Female; Humans; Immunocompromised Host; Lipopeptides; Middle Aged; Pyrimidines; Sacroiliac Joint; Treatment Outcome; Triazoles; Voriconazole	2011
Breakthrough Saprochaete capitata infections in patients receiving echinocandins: case report and review of the literature. Medical mycology, 2011, Volume: 49, Issue:4 Topics: Aged; Antifungal Agents; Caspofungin; Child; Echinocandins; Fatal Outcome; Female; Geotrichosis; Geotrichum; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole	2011
Invasive aspergillosis in patients with liver disease. Medical mycology, 2011, Volume: 49, Issue:4 Topics: Aged; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Fatal Outcome; Humans; Lipopeptides; Liver Diseases; Lung; Male; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole	2011
[Combination therapy for invasive aspergillosis]. Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29 Suppl 2 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Echinocandins; Forecasting; Fungemia; Guinea Pigs; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Meningitis, Fungal; Micafungin; Mice; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Retrospective Studies; Triazoles	2011
Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature. European journal of medical research, 2011, Apr-28, Volume: 16, Issue:4 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Therapy, Combination; Echinocandins; Evidence-Based Medicine; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Pyrimidines; Risk Factors; Triazoles; Voriconazole	2011
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2012, Volume: 16, Issue:1 Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Mycoses; North America; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole	2012
Endophthalmitis caused by Phialophora verrucosa: a case report and literature review of Phialophora ocular infections. Enfermedades infecciosas y microbiologia clinica, 2012, Volume: 30, Issue:3 Topics: Aged; Amphotericin B; Antifungal Agents; Caspofungin; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Glaucoma; Humans; Hypertension; Intravitreal Injections; Lipopeptides; Male; Phialophora; Pyrimidines; Triazoles; Vitrectomy; Voriconazole	2012
Diagnosis of airway-invasive pulmonary aspergillosis by tree-in-bud sign in an immunocompetent patient: case report and literature review. Journal de mycologie medicale, 2013, Volume: 23, Issue:1 Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Biopsy; Bronchiolitis; Bronchoscopy; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Humans; Immunocompetence; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Lung; Male; Pyrimidines; Sputum; Tomography, X-Ray Computed; Triazoles; Tuberculosis, Pulmonary; Voriconazole; Young Adult	2013
Combination antifungal therapy for invasive fungal infections in children and adults. Expert review of anti-infective therapy, 2013, Volume: 11, Issue:5 Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Caspofungin; Child; Cryptococcosis; Cryptococcus; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Pyrimidines; Triazoles; Voriconazole	2013
Dosing of antifungal agents in obese people. Expert review of anti-infective therapy, 2016, Volume: 14, Issue:2 Topics: Amphotericin B; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Mycoses; Nitriles; Obesity; Pyridines; Triazoles	2016
Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options. The Annals of pharmacotherapy, 2016, Volume: 50, Issue:9 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Debridement; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Mucorales; Mucormycosis; Nitriles; Pyridines; Triazoles; Virulence	2016
Isavuconazole in a Successful Combination Treatment of Disseminated Mucormycosis in a Child with Acute Lymphoblastic Leukaemia and Generalized Haemochromatosis: A Case Report and Review of the Literature. Mycopathologia, 2019, Volume: 184, Issue:1 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Cunninghamella; Debridement; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Hemochromatosis; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyridines; Treatment Outcome; Triazoles	2019
Therapeutic tools for oral candidiasis: Current and new antifungal drugs. Medicina oral, patologia oral y cirugia bucal, 2019, Mar-01, Volume: 24, Issue:2 Topics: Administration, Intravenous; Administration, Oral; Administration, Topical; Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candidiasis, Oral; Caspofungin; Clotrimazole; Databases, Factual; Drug Interactions; Echinocandins; Fluconazole; Humans; Miconazole; Nitriles; Nystatin; Pyridines; Triazoles	2019
New Perspectives on Antimicrobial Agents: Isavuconazole. Antimicrobial agents and chemotherapy, 2022, 09-20, Volume: 66, Issue:9 Topics: Antifungal Agents; Candidiasis, Invasive; Caspofungin; Fungi; Humans; Invasive Fungal Infections; Nitriles; Pyridines; Triazoles; Voriconazole	2022

Trials

8 trial(s) available for triazoles and l 743,872

Article	Year
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation, 2006, Feb-15, Volume: 81, Issue:3 Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Renal Insufficiency; Treatment Outcome; Triazoles; Voriconazole	2006
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Leukemia, 2008, Volume: 22, Issue:3 Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole	2008
Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia. European journal of haematology, 2010, Volume: 84, Issue:3 Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Mycoses; Neutropenia; Prospective Studies; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole; Young Adult	2010
Lack of pharmacokinetic drug interaction between oral posaconazole and caspofungin or micafungin. Journal of clinical pharmacology, 2011, Volume: 51, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Area Under Curve; Caspofungin; Drug Interactions; Echinocandins; Female; Humans; Infusions, Intravenous; Lipopeptides; Male; Micafungin; Triazoles; Young Adult	2011
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2011, Volume: 15, Issue:5 Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fever; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Prospective Studies; Pyrimidines; Radiography, Thoracic; Risk Factors; Singapore; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole	2011
Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia. Mycoses, 2012, Volume: 55, Issue:3 Topics: Antifungal Agents; Australia; Caspofungin; Echinocandins; Economics, Pharmaceutical; Fever; Humans; Lipopeptides; Male; Neutropenia; Pyrimidines; Triazoles; Voriconazole	2012
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 05-30, Volume: 68, Issue:12 Topics: Adult; Aged; Candida; Candidemia; Candidiasis, Invasive; Caspofungin; Female; Humans; Male; Middle Aged; Nitriles; Pyridines; Treatment Outcome; Triazoles	2019
A Randomized Trial of Caspofungin vs Triazoles Prophylaxis for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplant. Journal of the Pediatric Infectious Diseases Society, 2021, Apr-30, Volume: 10, Issue:4 Topics: Adolescent; Adult; Antifungal Agents; Caspofungin; Child; Child, Preschool; Hematopoietic Stem Cell Transplantation; Humans; Infant; Invasive Fungal Infections; Mycoses; Triazoles; Young Adult	2021

Other Studies

286 other study(ies) available for triazoles and l 743,872

Article	Year
Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. Journal of clinical microbiology, 1998, Volume: 36, Issue:10 Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Culture Media; Echinocandins; Fungi; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Structure-Activity Relationship; Triazoles; Yeasts	1998
[Antifungal drugs: the new frontier]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 1998, Volume: 11, Issue:3 Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Caspofungin; Drug Resistance, Microbial; Echinocandins; Female; Fungi; Humans; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Trypanocidal Agents; Voriconazole	1998
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. Journal of clinical microbiology, 1999, Volume: 37, Issue:3 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole	1999
Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:8 Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Guinea Pigs; Lipopeptides; Male; Organ Culture Techniques; Peptides; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Voriconazole	2002
In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:9 Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Drug Interactions; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2002
Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility test Journal of clinical microbiology, 2002, Volume: 40, Issue:10 Topics: Anti-Bacterial Agents; Antifungal Agents; Candida; Caspofungin; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Quality Control; Saccharomyces cerevisiae; Triazoles; Voriconazole	2002
New drugs, old drugs - dear drugs, cheap drugs. Swiss medical weekly, 2002, Jun-15, Volume: 132, Issue:23-24 Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bone Marrow Transplantation; Caspofungin; Cyclosporine; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Renal Insufficiency; Triazoles; Voriconazole	2002
In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp. Diagnostic microbiology and infectious disease, 2003, Volume: 45, Issue:2 Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Time Factors; Triazoles; Voriconazole	2003
Comment: caspofungin acetate for treatment of invasive fungal infections. The Annals of pharmacotherapy, 2003, Volume: 37, Issue:4 Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Guinea Pigs; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2003
Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus. The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:6 Topics: Aspergillus fumigatus; Caspofungin; Drug Interactions; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Triazoles	2003
Voriconazole inhibits fungal growth without impairing antigen presentation or T-cell activation. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:6 Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antigen Presentation; Aspergillosis; Aspergillus fumigatus; Caspofungin; Dendritic Cells; Echinocandins; Lipopeptides; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peptides; Peptides, Cyclic; Pyrimidines; Specific Pathogen-Free Organisms; T-Lymphocytes; Triazoles; Voriconazole	2003
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. Journal of clinical microbiology, 2003, Volume: 41, Issue:8 Topics: Amphotericin B; Anti-Bacterial Agents; Aspergillus; Caspofungin; Echinocandins; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Penicillium; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole	2003
Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapy. Medical mycology, 2003, Volume: 41, Issue:4 Topics: Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Brain Abscess; Brain Diseases; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Immunologic Deficiency Syndromes; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2003
Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2003, Nov-15, Volume: 60, Issue:22 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Neutropenia; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2003
Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient. Annals of hematology, 2004, Volume: 83, Issue:6 Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Leukemia, Myelomonocytic, Acute; Lipopeptides; Male; Middle Aged; Peptides; Peptides, Cyclic; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole	2004
Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp. Journal of clinical microbiology, 2004, Volume: 42, Issue:2 Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Colorimetry; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Reproducibility of Results; Sensitivity and Specificity; Triazoles	2004
[symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections. Drug and therapeutics bulletin, 2004, Volume: 42, Issue:1 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole	2004
Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:3 Topics: Adolescent; Amphotericin B; Bone Marrow Transplantation; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Humans; Leukemia; Lipopeptides; Liposomes; Male; Peptides; Peptides, Cyclic; Pneumonia; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole	2004
Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease. Bone marrow transplantation, 2004, Volume: 33, Issue:10 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lipopeptides; Lung; Middle Aged; Peptides, Cyclic; Pyrimidines; Tomography, X-Ray Computed; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis	2004
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:5 Topics: Antifungal Agents; Aspergillus fumigatus; Calcineurin; Calcineurin Inhibitors; Caspofungin; Cyclosporine; Drug Interactions; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole	2004
Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis. European journal of haematology, 2004, Volume: 73, Issue:1 Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Child; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Geotrichosis; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Liposomes; Male; Mycoses; Myelodysplastic Syndromes; Peptides; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole	2004
Successful elimination of an invasive Aspergillus nidulans lung infection by voriconazole after failure of a combination of caspofungin and liposomal amphotericin B in a boy with chronic granulomatous disease. The Pediatric infectious disease journal, 2004, Volume: 23, Issue:6 Topics: Adolescent; Amphotericin B; Aspergillosis; Aspergillus nidulans; Caspofungin; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Granulomatous Disease, Chronic; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Risk Assessment; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole	2004
Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole. Transplant infectious disease : an official journal of the Transplantation Society, 2004, Volume: 6, Issue:1 Topics: Adult; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Female; Humans; Lipopeptides; Liver Transplantation; Peptides; Peptides, Cyclic; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole	2004
Effects of several antifungal drug combinations against clinical and environmental isolates of Cryptococcus neoformans from China. Mycoses, 2004, Volume: 47, Issue:7 Topics: Animals; Antifungal Agents; Caspofungin; China; Columbidae; Cryptococcosis; Cryptococcus neoformans; Drug Interactions; Echinocandins; Feces; Flucytosine; Humans; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine; Thiazoles; Triazoles	2004
Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma. Leukemia & lymphoma, 2004, Volume: 45, Issue:10 Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis, Allergic Bronchopulmonary; Caspofungin; Echinocandins; Fatal Outcome; Female; Humans; Kidney Transplantation; Lipopeptides; Lymphoma, Non-Hodgkin; Middle Aged; Mucormycosis; Peptides, Cyclic; Pyrimidines; Treatment Failure; Triazoles; Voriconazole	2004
Antifungal therapy in patients with fever and neutropenia--more rational and less empirical? The New England journal of medicine, 2004, Sep-30, Volume: 351, Issue:14 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Liposomes; Mycoses; Neoplasms; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2004
Combination antifungal therapy for invasive aspergillosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Sep-15, Volume: 39, Issue:6 Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole	2004
Combination therapy for invasive aspergillosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Sep-15, Volume: 39, Issue:6 Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2004
In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:11 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Fluconazole; Hematologic Neoplasms; Humans; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Models, Biological; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2004
In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:11 Topics: Aminoglycosides; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Interactions; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Polyenes; Triazoles	2004
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:12 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Calcineurin Inhibitors; Caspofungin; Cyclosporine; Echinocandins; Humans; Immunosuppressive Agents; Lipopeptides; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole	2004
Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. American journal of ophthalmology, 2005, Volume: 139, Issue:1 Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Aqueous Humor; Biological Availability; Candidiasis; Caspofungin; Chromatography, High Pressure Liquid; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Female; Fungemia; Humans; Infusions, Intravenous; Injections; Lipopeptides; Male; Middle Aged; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Triazoles; Vitreous Body; Voriconazole	2005
Caspofungin versus liposomal amphotericin B for empirical therapy. The New England journal of medicine, 2005, Jan-27, Volume: 352, Issue:4 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Mycoses; Neutropenia; Peptides, Cyclic; Triazoles	2005
Caspofungin versus liposomal amphotericin B for empirical therapy. The New England journal of medicine, 2005, Jan-27, Volume: 352, Issue:4 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Infusions, Intravenous; Lipopeptides; Liposomes; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2005
Caspofungin versus liposomal amphotericin B for empirical therapy. The New England journal of medicine, 2005, Jan-27, Volume: 352, Issue:4 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Survival Rate; Triazoles; Voriconazole	2005
[Drugs used in prophylaxis and treatment of fungal infections in immunosuppressed children]. Przeglad lekarski, 2004, Volume: 61 Suppl 2 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Drug Resistance, Fungal; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Neoplasms; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole	2004
Successful antifungal combination therapy with voriconazole and caspofungin. Pediatric blood & cancer, 2005, Jun-15, Volume: 44, Issue:7 Topics: Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Child, Preschool; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole	2005
Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:3 Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2005
Cerebral aspergillosis in the critically ill: two cases of successful medical treatment. Intensive care medicine, 2005, Volume: 31, Issue:5 Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Intensive Care Units; Lipopeptides; Male; Middle Aged; Neuroaspergillosis; Peptides, Cyclic; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole	2005
Successful treatment of disseminated aspergillosis with the combination of voriconazole, caspofungin, granulocyte transfusions, and surgery followed by allogeneic blood stem cell transplantation in a patient with primary failure of an autologous stem cell European journal of haematology, 2005, Volume: 74, Issue:5 Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Granulocytes; Humans; Leukocyte Transfusion; Lipopeptides; Magnetic Resonance Imaging; Male; Melphalan; Middle Aged; Multiple Myeloma; Necrosis; Peptides, Cyclic; Pyrimidines; Radiography; Stem Cell Transplantation; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole	2005
Combination antifungal therapy for invasive aspergillosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Apr-01, Volume: 40, Issue:7 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2005
Effect of media composition and in vitro activity of posaconazole, caspofungin and voriconazole against zygomycetes. The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:6 Topics: Absidia; Antifungal Agents; Caspofungin; Culture Media; Cunninghamella; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Mucor; Mucorales; Peptides, Cyclic; Pyrimidines; Rhizopus; Triazoles; Voriconazole	2005
In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8 Topics: Antifungal Agents; Candida glabrata; Candidiasis, Oral; Caspofungin; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Triazoles	2005
Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:9 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Echinocandins; Guinea Pigs; Kidney; Lipopeptides; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Voriconazole	2005
Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin. American journal of ophthalmology, 2005, Volume: 140, Issue:3 Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Cataract Extraction; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Fusarium; Humans; Lens Implantation, Intraocular; Lipopeptides; Male; Middle Aged; Mycoses; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Voriconazole	2005
Comparison of two probes for testing susceptibilities of pathogenic yeasts to voriconazole, itraconazole, and caspofungin by flow cytometry. Journal of clinical microbiology, 2005, Volume: 43, Issue:9 Topics: Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Echinocandins; Flow Cytometry; Fluorescent Dyes; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Propidium; Pyrimidines; Triazoles; Voriconazole	2005
Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. British journal of haematology, 2005, Volume: 131, Issue:2 Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Austria; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Genes, Fungal; Hematologic Neoplasms; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Organ Transplantation; Peptides, Cyclic; Prevalence; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole	2005
Advances in antifungal therapy. The Pediatric infectious disease journal, 2005, Volume: 24, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Animals; Antifungal Agents; Caspofungin; Child; Child, Preschool; Clinical Trials as Topic; Echinocandins; Fungal Proteins; Humans; Infant; Infant, Newborn; Lipopeptides; Lipoproteins; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Thiazoles; Treatment Outcome; Triazoles; Voriconazole	2005
[Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole]. Recenti progressi in medicina, 2005, Volume: 96, Issue:9 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Mycoses; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2005
Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis. Infection, 2005, Volume: 33, Issue:5-6 Topics: Aged; Amphotericin B; Anemia, Aplastic; Ascomycota; Aspergillosis; Body Fluids; Caspofungin; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Mycoses; Peptides, Cyclic; Pyrimidines; Saccharomycetales; Shock, Septic; Triazoles; Voriconazole	2005
Mediastinal mass due to Aspergillus fumigatus after lung transplantation: a case report. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2005, Volume: 24, Issue:11 Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cystic Fibrosis; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Magnetic Resonance Imaging; Mediastinal Diseases; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Recurrence; Thoracoscopy; Triazoles; Voriconazole	2005
Autologous transplantation of CD133 selected hematopoietic progenitor cells for treatment of relapsed acute lymphoblastic leukemia. Pediatric blood & cancer, 2007, Volume: 48, Issue:3 Topics: AC133 Antigen; Amphotericin B; Antifungal Agents; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Caspofungin; Child; Combined Modality Therapy; Contraindications; Dexamethasone; Drug Therapy, Combination; Echinocandins; Glycoproteins; Humans; Immunomagnetic Separation; Lipopeptides; Male; Mercaptopurine; Methotrexate; Peptides; Peptides, Cyclic; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Vincristine; Voriconazole; Zygomycosis	2007
Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:12 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Central Nervous System Fungal Infections; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Echinocandins; Lipopeptides; Lipoproteins; Liposomes; Micafungin; Mice; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2005
Aspergillus flavus scleritis: successful treatment with voriconazole and caspofungin. Medical mycology, 2005, Volume: 43, Issue:7 Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Pyrimidines; Scleritis; Treatment Outcome; Triazoles; Voriconazole	2005
Septic Candida krusei thrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents. Medical mycology, 2005, Volume: 43, Issue:8 Topics: Adult; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Intensive Care Units; Lipopeptides; Peptides, Cyclic; Pyrimidines; Thrombophlebitis; Triazoles; Vena Cava, Inferior; Voriconazole	2005
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:3 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts	2006
Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:3 Topics: Amphotericin B; Antifungal Agents; Biofilms; Biomass; Caspofungin; Cryptococcus neoformans; Dose-Response Relationship, Drug; Echinocandins; Enzyme-Linked Immunosorbent Assay; Fluconazole; Formazans; Lipopeptides; Melanins; Microbial Sensitivity Tests; Microscopy, Confocal; Peptides, Cyclic; Plankton; Pyrimidines; Triazoles; Voriconazole	2006
Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole. BMC infectious diseases, 2006, Apr-11, Volume: 6 Topics: Antifungal Agents; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Endocarditis; Female; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2006
Spondylodiscitis caused by Candida krusei: case report and susceptibility patterns. Journal of clinical microbiology, 2006, Volume: 44, Issue:5 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Discitis; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Middle Aged; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2006
In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Synergism; Echinocandins; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Peptides, Cyclic; Pyrimidines; Terbinafine; Triazoles; Voriconazole	2006
Unclear fever 7 weeks after renal transplantation in a 56-year-old patient. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:8 Topics: Abscess; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biopsy, Fine-Needle; Caspofungin; Contraindications; Cyclosporine; Delayed Graft Function; Drug Interactions; Echinocandins; Fever of Unknown Origin; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lipopeptides; Male; Middle Aged; Mycophenolic Acid; Peptides, Cyclic; Postoperative Complications; Prednisone; Pyrimidines; Radionuclide Imaging; Stenotrophomonas maltophilia; Surgical Wound Infection; Thyroiditis; Triazoles; Ultrasonography; Voriconazole	2006
Interaction between posaconazole and caspofungin in concomitant treatment of mice with systemic Aspergillus infection. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:7 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Drug Interactions; Drug Therapy, Combination; Echinocandins; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Peptides, Cyclic; Triazoles	2006
A case of pulmonary aspergillosis with lack of response to caspofungin. Revista iberoamericana de micologia, 2006, Volume: 23, Issue:2 Topics: Acute Disease; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Diseases; Candidiasis; Caspofungin; Combined Modality Therapy; Contraindications; Echinocandins; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hepatitis; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid; Lipopeptides; Lung Diseases, Fungal; Middle Aged; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Splenic Diseases; Triazoles; Voriconazole	2006
Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment? European journal of haematology, 2006, Volume: 77, Issue:4 Topics: Adult; Aged; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Peptides, Cyclic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole	2006
Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman. International journal of antimicrobial agents, 2006, Volume: 28, Issue:3 Topics: Adult; Amphotericin B; Antifungal Agents; Arthritis; Aspergillus fumigatus; Brain; Brain Abscess; Caspofungin; Chromatography, Liquid; Echinocandins; Female; Humans; Lipopeptides; Magnetic Resonance Imaging; Mass Spectrometry; Neuroaspergillosis; Paranasal Sinus Diseases; Peptides, Cyclic; Pyrimidines; Staphylococcus aureus; Triazoles; Voriconazole	2006
Disseminated invasive aspergillosis in a patient with acute leukaemia. Acta bio-medica : Atenei Parmensis, 2006, Volume: 77 Suppl 2 Topics: Acute Kidney Injury; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bacteremia; Caspofungin; Chlamydophila Infections; Chlamydophila pneumoniae; Doxorubicin; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Lipopeptides; Liposomes; Lung Diseases, Fungal; Medical Futility; Methotrexate; Middle Aged; Neuroaspergillosis; Peptides, Cyclic; Pneumonia, Bacterial; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Streptococcal Infections; Triazoles; Vincristine; Voriconazole	2006
Antifungal effects on metabolite profiles of medically important yeast species measured by nuclear magnetic resonance spectroscopy. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12 Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Caspofungin; Echinocandins; Indicator Dilution Techniques; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Pyrimidines; Triazoles; Trichosporon; Voriconazole	2006
Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:11 Topics: Adult; Amphotericin B; Antifungal Agents; Benzoates; Brain Stem; Caspofungin; Cavernous Sinus; Central Nervous System Fungal Infections; Deferasirox; Diabetic Ketoacidosis; Drug Therapy, Combination; Echinocandins; Humans; Iron Chelating Agents; Lipopeptides; Magnetic Resonance Imaging; Male; Mucormycosis; Nose Diseases; Peptides, Cyclic; Salvage Therapy; Triazoles	2006
Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole. Scandinavian journal of infectious diseases, 2006, Volume: 38, Issue:10 Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Male; Middle Aged; Panophthalmitis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2006
Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program. Journal of clinical microbiology, 2006, Volume: 44, Issue:10 Topics: Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Global Health; Humans; Lipopeptides; Peptides, Cyclic; Population Surveillance; Pyrimidines; Triazoles; Voriconazole	2006
Multi-azole resistance in Aspergillus fumigatus. International journal of antimicrobial agents, 2006, Volume: 28, Issue:5 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Itraconazole; Lipopeptides; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole	2006
Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species. The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:6 Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Drug Antagonism; Drug Combinations; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2006
Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus. The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:6 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Brain; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Fluorescence Resonance Energy Transfer; Immunocompromised Host; Immunosuppression Therapy; Itraconazole; Kidney; Lipopeptides; Liver; Lung; Male; Mice; Neutropenia; Nitriles; Peptides, Cyclic; Polymerase Chain Reaction; Pyrimidines; Survival Analysis; Triazoles; Voriconazole	2006
In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates. Diagnostic microbiology and infectious disease, 2007, Volume: 57, Issue:3 Topics: Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2007
Susceptibility of environmental versus clinical strains of pathogenic Aspergillus. International journal of antimicrobial agents, 2007, Volume: 29, Issue:1 Topics: Air Microbiology; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Cross Infection; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole; Water Microbiology	2007
Unexplained increase in Paecilomyces variotii blood culture isolates in the UK. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2006, Nov-16, Volume: 11, Issue:11 Topics: Amphotericin B; Antifungal Agents; Blood; Caspofungin; Diagnosis, Differential; Echinocandins; Equipment Contamination; False Positive Reactions; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Paecilomyces; Peptides, Cyclic; Pyrimidines; Species Specificity; Triazoles; United Kingdom; Voriconazole	2006
Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, cas Journal of clinical microbiology, 2007, Volume: 45, Issue:3 Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; Triazoles; Voriconazole	2007
Caspofungin for the treatment of azole resistant candidemia in a premature infant. Journal of perinatology : official journal of the California Perinatal Association, 2007, Volume: 27, Issue:2 Topics: Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Microbial; Echinocandins; Humans; Hypercalcemia; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lipopeptides; Male; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2007
Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Spain. Clinical drug investigation, 2007, Volume: 27, Issue:3 Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Body Weight; Caspofungin; Cost-Benefit Analysis; Echinocandins; Health Care Costs; Humans; Injections, Intravenous; Lipopeptides; Multivariate Analysis; Peptides, Cyclic; Pyrimidines; Severity of Illness Index; Spain; Treatment Outcome; Triazoles; Voriconazole	2007
The effects of caspofungin and voriconazole in experimental Candida endophthalmitis. Current eye research, 2007, Volume: 32, Issue:1 Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Cornea; Disease Models, Animal; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Itraconazole; Lipopeptides; Peptides, Cyclic; Pyrimidines; Rabbits; Triazoles; Voriconazole	2007
Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Dose-Response Relationship, Drug; Drug Antagonism; Drug Interactions; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Models, Biological; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2007
Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin. Journal of clinical microbiology, 2007, Volume: 45, Issue:6 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Culture Media; Disk Diffusion Antimicrobial Tests; Echinocandins; Fungi; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole	2007
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2007
Successful management of Aspergillus liver abscess in a patient with necrotizing fasciitis. Digestive diseases and sciences, 2007, Volume: 52, Issue:6 Topics: Adult; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Fasciitis, Necrotizing; Female; Humans; Lipopeptides; Liver Abscess; Peptides, Cyclic; Pregnancy; Pyrimidines; Triazoles; Voriconazole	2007
Acquired resistance to echinocandins in Candida albicans: case report and review. The Journal of antimicrobial chemotherapy, 2007, Volume: 59, Issue:6 Topics: Adult; Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Genotype; HIV Infections; HIV-1; Humans; Lipopeptides; Lipoproteins; Male; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Peptides, Cyclic; Pyrimidines; Treatment Failure; Triazoles; Voriconazole	2007
Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report. BMC infectious diseases, 2007, May-10, Volume: 7 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Female; Fusarium; Humans; Lipopeptides; Mycoses; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2007
Diagnostic and therapeutic challenge of Aspergillus flavus scleritis. Cornea, 2007, Volume: 26, Issue:5 Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Drug Therapy, Combination; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Pyrimidines; Scleritis; Substance Abuse, Intravenous; Triazoles; Voriconazole	2007
Secular trends in severe renal failure associated with the use of new antimicrobial agents in critically ill surgical patients. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2007, Volume: 26, Issue:6 Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Caspofungin; Cohort Studies; Critical Illness; Echinocandins; Female; Humans; Intensive Care Units; Linezolid; Lipopeptides; Male; Middle Aged; Oxazolidinones; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Renal Insufficiency; Renal Replacement Therapy; Retrospective Studies; Triazoles; Voriconazole	2007
Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach. The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:2 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Cost-Benefit Analysis; Costs and Cost Analysis; Data Interpretation, Statistical; Decision Trees; Drug Combinations; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Models, Economic; Models, Statistical; Netherlands; Pyrimidines; Reproducibility of Results; Survival Analysis; Triazoles; Voriconazole	2007
Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. Archives of ophthalmology (Chicago, Ill. : 1960), 2007, Volume: 125, Issue:6 Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Corneal Ulcer; Echinocandins; Eye Infections, Fungal; Fusarium; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Natamycin; Peptides, Cyclic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole	2007
Multifocal Scedosporium apiospermum spondylitis in a cystic fibrosis patient. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2008, Volume: 7, Issue:1 Topics: Adult; Antifungal Agents; Caspofungin; Cystic Fibrosis; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Male; Mycetoma; Pleurisy; Pyrimidines; Scedosporium; Spondylitis; Thoracic Vertebrae; Triazoles; Voriconazole	2008
Synergistic effect of posaconazole and caspofungin against clinical zygomycetes. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9 Topics: Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Fungi; Lipopeptides; Microbial Sensitivity Tests; Triazoles	2007
In vitro activity of fluconazole, voriconazole and caspofungin against clinical yeast isolates. Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:3 Topics: Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2007
Basidiomycetous fungal Inonotus tropicalis sacral osteomyelitis in X-linked chronic granulomatous disease. The Pediatric infectious disease journal, 2007, Volume: 26, Issue:7 Topics: Adult; Antifungal Agents; Basidiomycota; Caspofungin; Echinocandins; Granulomatous Disease, Chronic; HMGB1 Protein; Humans; Lipopeptides; Male; Mycoses; Osteomyelitis; Peptides, Cyclic; Pyrimidines; Sacrum; Triazoles; Voriconazole	2007
Caspofungin-resistant Aspergillus flavus after heart transplantation and mechanical circulatory support: a case report. Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:3 Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Extracorporeal Membrane Oxygenation; Female; Heart Transplantation; Heart-Assist Devices; Humans; Lipopeptides; Middle Aged; Pyrimidines; Triazoles; Voriconazole	2008
Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10 Topics: Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Colletotrichum; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fungi; Fungicides, Industrial; Humans; In Vitro Techniques; Lipopeptides; Microbial Sensitivity Tests; Microscopy, Fluorescence; Nystatin; Plant Diseases; Skin; Triazoles	2007
Treatment of two postoperative endophthalmitis cases due to Aspergillus flavus and Scopulariopsis spp. with local and systemic antifungal therapy. BMC infectious diseases, 2007, Jul-31, Volume: 7 Topics: Aged; Amphotericin B; Antifungal Agents; Ascomycota; Aspergillus flavus; Caspofungin; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Humans; Lipopeptides; Male; Postoperative Complications; Pyrimidines; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole	2007
Disseminated invasive aspergillosis with cerebral involvement successfully treated with caspofungin and voriconazole. Infection, 2007, Volume: 35, Issue:5 Topics: Adult; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Encephalitis; Humans; Lipopeptides; Male; Neuroaspergillosis; Pyrimidines; Triazoles; Voriconazole	2007
Successfully treated Candida krusei infection of the lumbar spine with combined caspofungin/posaconazole therapy. Medical mycology, 2008, Volume: 46, Issue:1 Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Triazoles	2008
In vitro activities of voriconazole as a triazole derivative and caspofungin as an echinocandin were compared with those of some antifungal agents against Candida species isolated from clinical specimens. Japanese journal of infectious diseases, 2007, Volume: 60, Issue:5 Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Sputum; Triazoles; Voriconazole	2007
Efficacy of caspofungin and posaconazole in a murine model of disseminated Exophiala infection. Medical mycology, 2007, Volume: 45, Issue:8 Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Caspofungin; Disease Models, Animal; Echinocandins; Exophiala; Female; Immunocompromised Host; Kidney; Lipopeptides; Mice; Mice, Inbred ICR; Mycoses; Survival Analysis; Triazoles	2007
Combined voriconazole plus caspofungin therapy for the treatment of probable Geotrichum pneumonia in a leukemia patient. Infection, 2008, Volume: 36, Issue:1 Topics: Aged; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Leukemia, Plasma Cell; Lipopeptides; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole	2008
Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation. European journal of medical research, 2007, Aug-16, Volume: 12, Issue:8 Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia-Lymphoma, Adult T-Cell; Lipopeptides; Liposomes; Male; Peptides, Cyclic; Pyrimidines; Transplantation Conditioning; Transplantation, Homologous; Triazoles; Voriconazole	2007
Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin. International journal of antimicrobial agents, 2007, Volume: 30, Issue:6 Topics: Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole	2007
Adjuvant endobronchial amphotericin B for refractory invasive pulmonary aspergillosis: evidence is scarce but promise does exist. Respiration; international review of thoracic diseases, 2007, Volume: 74, Issue:6 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Chemotherapy, Adjuvant; Drug Evaluation; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lung Diseases, Fungal; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2007
Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2 Topics: Amphotericin B; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Colony Count, Microbial; Drug Administration Schedule; Echinocandins; Humans; Kidney; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Treatment Outcome; Triazoles	2008
Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets. Chemotherapy, 2008, Volume: 54, Issue:1 Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Pyrimidines; Rhodotorula; Triazoles; Trichosporon; Voriconazole	2008
Multilaboratory testing of antifungal combinations against a quality control isolate of Candida krusei. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Laboratories; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Triazoles; Voriconazole	2008
[Antifungal activity of posaconazole and caspofungin in yeast causing invasive fungal infection (2002-2003). E-test system evaluation]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26, Issue:2 Topics: Antifungal Agents; Candida; Caspofungin; Cryptococcus; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Rhodotorula; Sensitivity and Specificity; Species Specificity; Triazoles	2008
Successful treatment of invasive Aspergillus sinusitis with caspofungin and voriconazole. Ear, nose, & throat journal, 2008, Volume: 87, Issue:1 Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole	2008
[Cutaneous, pulmonary and bone aspergillosis in a patient presumed immunocompetent presenting subacute cutaneous lupus erythematosus]. Annales de dermatologie et de venereologie, 2008, Volume: 135, Issue:3 Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Bone Diseases, Infectious; Caspofungin; Echinocandins; Humans; Lipopeptides; Lung; Lung Diseases, Fungal; Lupus Erythematosus, Systemic; Male; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole	2008
Successful treatment of disseminated Geotrichum capitatum infection with a combination of caspofungin and voriconazole in an immunocompromised patient. Mycoses, 2008, Volume: 51, Issue:3 Topics: Antifungal Agents; Caspofungin; Drug Combinations; Echinocandins; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole	2008
Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, May-15, Volume: 46, Issue:10 Topics: Adolescent; Antifungal Agents; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Hematologic Neoplasms; Humans; Lipopeptides; Male; Mycoses; Neutropenia; Pneumonia; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Triazoles; Trichoderma; Voriconazole	2008
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2008
Disseminated aspergillosis in an adolescent with acute lymphoblastic leukemia. Pediatric blood & cancer, 2008, Volume: 51, Issue:3 Topics: Adolescent; Aspergillosis; Aspergillus fumigatus; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Thyroid Diseases; Tomography, X-Ray Computed; Triazoles; Voriconazole	2008
Antifungal activity against Candida albicans of nikkomycin Z in combination with caspofungin, voriconazole or amphotericin B. The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:3 Topics: Aminoglycosides; Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2008
Effective management of pulmonary aspergillosis invading the thoracic spine in a child with high risk ALL requiring allogeneic bone marrow transplantation. Medical mycology, 2008, Volume: 46, Issue:5 Topics: Adoptive Transfer; Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Bone Marrow Transplantation; Caspofungin; Child; Echinocandins; Female; Graft vs Host Disease; Granulocytes; Humans; Lipopeptides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography, Thoracic; Spine; Triazoles; Voriconazole	2008
Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study. Journal of clinical microbiology, 2008, Volume: 46, Issue:9 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fluconazole; Humans; Infant; Infant, Newborn; Itraconazole; Lipopeptides; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Thiazoles; Triazoles; Voriconazole; Young Adult	2008
In vitro synergy of caspofungin with licensed and novel antifungal drugs against clinical isolates of Fusarium spp. Medical mycology, 2009, Volume: 47, Issue:5 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Fusarium; Humans; Hyphae; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Tacrolimus; Terbinafine; Triazoles; Voriconazole	2009
Anticandidal effects of voriconazole and caspofungin, singly and in combination, against Candida glabrata, extracellularly and intracellularly in granulocyte-macrophage colony stimulating factor (GM-CSF)-activated human monocytes. The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:6 Topics: Antifungal Agents; Candida glabrata; Caspofungin; Cells, Cultured; Drug Interactions; Echinocandins; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Monocytes; Pyrimidines; Triazoles; Voriconazole	2008
Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation. Intensive care medicine, 2009, Volume: 35, Issue:1 Topics: Adult; Antifungal Agents; Caspofungin; Echinocandins; Extracorporeal Membrane Oxygenation; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Myocarditis; Pyrimidines; Shock, Cardiogenic; Triazoles; Voriconazole	2009
Alternaria infectoria brain abscess in a child with chronic granulomatous disease. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2009, Volume: 28, Issue:4 Topics: Alternaria; Antifungal Agents; Brain; Brain Abscess; Caspofungin; Child, Preschool; Echinocandins; Fatal Outcome; Granulomatous Disease, Chronic; Humans; Lipopeptides; Male; Mycoses; Pyrimidines; Radiography; RNA, Fungal; RNA, Ribosomal, 5.8S; Seizures; Triazoles; Voriconazole	2009
Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms. The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:6 Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Biofilms; Caspofungin; Echinocandins; Formazans; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Mycelium; Oxidation-Reduction; Pyrimidines; Spores, Fungal; Triazoles; Voriconazole	2008
In vitro susceptibility of Pythium insidiosum and a Lagenidium sp to itraconazole, posaconazole, voriconazole, terbinafine, caspofungin, and mefenoxam. American journal of veterinary research, 2008, Volume: 69, Issue:11 Topics: Alanine; Anti-Infective Agents; Caspofungin; Echinocandins; In Vitro Techniques; Itraconazole; Lagenidium; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Pythium; Terbinafine; Triazoles; Voriconazole	2008
Alternaria keratitis: clinical presentation and resolution with topical fluconazole or intrastromal voriconazole and topical caspofungin. Cornea, 2009, Volume: 28, Issue:1 Topics: Administration, Topical; Adult; Aged; Alternaria; Antifungal Agents; Caspofungin; Cataract Extraction; Contact Lenses; Corneal Stroma; Drug Therapy, Combination; Echinocandins; Eye Infections, Fungal; Eye Injuries; Female; Fluconazole; Humans; Injections; Keratitis; Lipopeptides; Male; Medical Records; Middle Aged; Pyrimidines; Steroids; Treatment Outcome; Triazoles; Voriconazole	2009
In vitro activity of caspofungin and voriconazole against uncommon Candida spp. International journal of antimicrobial agents, 2009, Volume: 33, Issue:6 Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2009
Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation. The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:4 Topics: Adolescent; Adult; Antifungal Agents; Caspofungin; Critical Illness; Echinocandins; Extracorporeal Membrane Oxygenation; Humans; Lipopeptides; Male; Plasma; Pyrimidines; Triazoles; Voriconazole	2009
[Invasive pulmonary aspergillosis. Occurrence in a non-neutropenic female patient with abdominal sepsis]. Der Anaesthesist, 2009, Volume: 58, Issue:3 Topics: Abdomen; Antifungal Agents; Caspofungin; Colonic Neoplasms; Critical Illness; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Laparotomy; Lipopeptides; Middle Aged; Peritonitis; Physical Therapy Modalities; Postoperative Complications; Pyrimidines; Sepsis; Triazoles; Voriconazole	2009
Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin. Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:1 Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida; Candidiasis; Caspofungin; Catheter-Related Infections; Cross Infection; Echinocandins; Fungemia; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole	2009
Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases. Mycoses, 2010, Volume: 53, Issue:3 Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Colony Count, Microbial; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Triazoles	2010
[Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ]. Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:3 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Caspofungin; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Leukoencephalopathy, Progressive Multifocal; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole	2009
The effects of caspofungin and voriconazole in an experimental fungal infection of the ear due to Aspergillus. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2009, Volume: 266, Issue:11 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cyclophosphamide; Disease Models, Animal; Echinocandins; Immunocompromised Host; Immunosuppressive Agents; Lipopeptides; Otitis Media; Pyrimidines; Rabbits; Triamcinolone Acetonide; Triazoles; Voriconazole	2009
[Conservative management with new antifungals in a case of Candida prosthetic valve endocarditis]. Enfermedades infecciosas y microbiologia clinica, 2010, Volume: 28, Issue:1 Topics: Amphotericin B; Antifungal Agents; Bioprosthesis; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Endocarditis; Heart Valve Prosthesis; Humans; Lipopeptides; Liposomes; Male; Middle Aged; Photosensitivity Disorders; Postoperative Complications; Prosthesis-Related Infections; Pyrimidines; Triazoles; Voriconazole	2010
Compassionate use study of caspofungin in children with proven or suspected invasive mycosis or persistent febrile neutropenia. Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:2 Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Infant; Infant, Newborn; Lipopeptides; Male; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Salvage Therapy; Triazoles; Voriconazole	2009
Infections caused by Candida krusei in five transplant and two surgical patients. Surgical infections, 2009, Volume: 10, Issue:3 Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis; Caspofungin; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA, Fungal; Echinocandins; Female; Genotype; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycological Typing Techniques; Organ Transplantation; Postoperative Complications; Pyrimidines; Random Amplified Polymorphic DNA Technique; Treatment Outcome; Triazoles; Voriconazole	2009
Successful management of postpneumonectomy Aspergillus pleural empyema by combined surgical and anti-fungal treatment with voriconazole and caspofungin. Mycoses, 2010, Volume: 53, Issue:5 Topics: Adult; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Empyema, Pleural; Female; Humans; Lipopeptides; Male; Middle Aged; Pneumonectomy; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2010
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. American journal of hematology, 2010, Volume: 85, Issue:3 Topics: Acute Disease; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus; Caspofungin; Combined Modality Therapy; Echinocandins; Humans; Hyphae; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Leukemia, B-Cell; Lipopeptides; Male; Middle Aged; Neutropenia; Spleen; Splenectomy; Splenic Diseases; Triazoles	2010
In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. International journal of antimicrobial agents, 2009, Volume: 34, Issue:3 Topics: Amphotericin B; Antifungal Agents; Antitubercular Agents; Caspofungin; Coccidioides; Coccidioidomycosis; Drug Synergism; Echinocandins; Ethambutol; Fluconazole; Humans; Isoniazid; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole	2009
Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis. The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:4 Topics: Antifungal Agents; Caspofungin; Echinocandins; Endophthalmitis; Fusarium; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole	2009
Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:7 Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Caspofungin; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungemia; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycological Typing Techniques; Polyenes; Population Surveillance; Prevalence; Triazoles	2010
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:7 Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Fungemia; Itraconazole; Laboratories, Hospital; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole; Yeasts	2010
[Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy]. Mikrobiyoloji bulteni, 2009, Volume: 43, Issue:3 Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillus flavus; Caspofungin; Chemotherapy, Adjuvant; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Injections, Intraventricular; Lipopeptides; Male; Neuroaspergillosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole	2009
Assessment of the in vitro kinetic activity of caspofungin against Candida glabrata. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Amphotericin B; Antifungal Agents; Azoles; Candida glabrata; Caspofungin; Drug Combinations; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fluconazole; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole	2010
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. Haematologica, 2010, Volume: 95, Issue:4 Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Prospective Studies; Pyrimidines; Registries; Survival Rate; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2010
Vertebral osteomyelitis due to Aspergillus fumigatus in a patient with chronic granulomatous disease successfully treated with antifungal agents and interferon-gamma. Medical mycology, 2010, Volume: 48, Issue:3 Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cervical Vertebrae; Drainage; Echinocandins; Granulomatous Disease, Chronic; Humans; Interferon-gamma; Itraconazole; Lipopeptides; Male; Osteomyelitis; Pyrimidines; Saudi Arabia; Thoracic Vertebrae; Treatment Outcome; Triazoles; Voriconazole	2010
A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections. Mycoses, 2011, Volume: 54, Issue:3 Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Female; Fungi; Hematologic Neoplasms; Humans; Infant; Lipopeptides; Male; Mycoses; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole	2011
Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT. Bone marrow transplantation, 2010, Volume: 45, Issue:7 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Prevalence; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole	2010
In vitro activity of antifungal combinations against Candida albicans biofilms. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:2 Topics: Amphotericin B; Antifungal Agents; Austria; Biofilms; Candida albicans; Candidiasis; Caspofungin; Drug Synergism; Echinocandins; Fungemia; Humans; Intensive Care Units; Lipopeptides; Microbial Sensitivity Tests; Triazoles	2010
Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia. Haematologica, 2010, Volume: 95, Issue:6 Topics: Adolescent; Adult; Aged; Air Pollutants; Caspofungin; Cohort Studies; Construction Materials; Echinocandins; Female; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult	2010
The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus. Medical mycology, 2010, Volume: 48, Issue:1 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Hyphae; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Spores, Fungal; Tetrazolium Salts; Triazoles; Voriconazole	2010
In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole	2010
Successful triple combination therapy of disseminated absidia corymbifera infection in an adolescent with osteosarcoma. Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:2 Topics: Absidia; Adolescent; Amphotericin B; Antineoplastic Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Femoral Neoplasms; Humans; Lipopeptides; Mucormycosis; Opportunistic Infections; Osteosarcoma; Triazoles	2010
Cunninghamella bertholletiae exhibits increased resistance to human neutrophils with or without antifungal agents as compared to Rhizopus spp. Medical mycology, 2010, Volume: 48, Issue:5 Topics: Adult; Antifungal Agents; Caspofungin; Cells, Cultured; Cunninghamella; Echinocandins; Enzyme-Linked Immunosorbent Assay; Humans; Interleukin-6; Interleukin-8; Lipopeptides; Microbial Viability; Neutrophils; Pyrimidines; Rhizopus; Tetrazolium Salts; Triazoles; Tumor Necrosis Factor-alpha; Voriconazole	2010
Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis. Journal of clinical pharmacy and therapeutics, 2010, Volume: 35, Issue:1 Topics: Adolescent; Adult; Antifungal Agents; Aspergillus; Caspofungin; Cystic Fibrosis; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung Transplantation; Male; Middle Aged; Pyrimidines; Retrospective Studies; Tacrolimus; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2010
Synergistic activities of three triazoles with caspofungin against Candida glabrata isolates determined by time-kill, Etest, and disk diffusion methods. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Antifungal Agents; Candida glabrata; Caspofungin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Endpoint Determination; Fluconazole; Itraconazole; Lipopeptides; Pyrimidines; Time Factors; Triazoles; Voriconazole	2010
In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii. International journal of antimicrobial agents, 2010, Volume: 35, Issue:6 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole	2010
Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis. Journal of clinical microbiology, 2010, Volume: 48, Issue:5 Topics: Adult; Antifungal Agents; Brain; Caspofungin; Chemoprevention; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Lung Transplantation; Magnetic Resonance Imaging; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Naphthalenes; Pseudallescheria; Pyrimidines; Radiography; RNA, Fungal; RNA, Ribosomal, 28S; Scedosporium; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole	2010
Chronic necrotizing and allergic bronchopulmonary aspergillosis in an asthmatic patient--a therapeutic challenge. The clinical respiratory journal, 2008, Volume: 2, Issue:4 Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Asthma; Bronchoscopy; Caspofungin; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Prognosis; Pyrimidines; Radiography, Thoracic; Recurrence; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole	2008
Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States. Mycoses, 2011, Volume: 54, Issue:5 Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Cohort Studies; Echinocandins; Female; Hospital Costs; Humans; Infusions, Intravenous; Invasive Pulmonary Aspergillosis; Length of Stay; Lipopeptides; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; United States; Voriconazole	2011
Invasive respiratory aspergillosis is a treatable disease with early diagnosis and aggressive therapy. Pediatric hematology and oncology, 2010, Volume: 27, Issue:6 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Early Diagnosis; Echinocandins; Female; Fever; Hematologic Neoplasms; Humans; Lipopeptides; Male; Neutropenia; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole	2010
Successful treatment of Scedosporium apiospermum soft tissue abscess with caspofungin and voriconazole in a severely immunocompromised patient with acute myeloid leukemia. Transplant infectious disease : an official journal of the Transplantation Society, 2010, Volume: 12, Issue:6 Topics: Abscess; Antifungal Agents; Caspofungin; Echinocandins; Female; Forearm; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Lipopeptides; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Soft Tissue Infections; Treatment Outcome; Triazoles; Voriconazole	2010
Successful topical application of caspofungin in the treatment of fungal keratitis refractory to voriconazole. Archives of ophthalmology (Chicago, Ill. : 1960), 2010, Volume: 128, Issue:7 Topics: Administration, Topical; Antifungal Agents; Candidiasis; Caspofungin; Corneal Ulcer; Drug Resistance, Fungal; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Pyrimidines; Triazoles; Voriconazole	2010
Effects of caspofungin, Candida albicans and Aspergillus fumigatus on toll-like receptor 9 of GM-CSF-stimulated PMNs. FEMS immunology and medical microbiology, 2010, Volume: 60, Issue:1 Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Caspofungin; CD11b Antigen; Cells, Cultured; Echinocandins; Gene Expression; Gene Expression Profiling; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunologic Factors; Interleukin-8; Lipopeptides; Neutrophils; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Toll-Like Receptors; Triazoles; Up-Regulation; Voriconazole	2010
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:9 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Guideline Adherence; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole	2010
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update. Bone marrow transplantation, 2011, Volume: 46, Issue:5 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lipopeptides; Micafungin; Mycoses; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole	2011
Generation of mutants in Candida albicans with reduced susceptibility to caspofungin: influence on other antifungal products. Journal of chemotherapy (Florence, Italy), 2010, Volume: 22, Issue:4 Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole	2010
Catheter-associated aspergillosis of the chest wall following allogeneic hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 2011, Volume: 13, Issue:2 Topics: Antifungal Agents; Aspergillosis; Caspofungin; Catheters; Child, Preschool; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Pyrimidines; Thoracic Wall; Transplantation, Homologous; Triazoles; Voriconazole	2011
Aspergillus thyroiditis in a renal transplant recipient mimicking subacute thyroiditis. Transplant infectious disease : an official journal of the Transplantation Society, 2011, Volume: 13, Issue:2 Topics: Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Kidney Transplantation; Lipopeptides; Pyrimidines; Thyroid Gland; Thyroiditis; Triazoles; Voriconazole	2011
Successful treatment of sellar aspergillus abscess. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2010, Volume: 17, Issue:12 Topics: Aged; Antifungal Agents; Brain Abscess; Caspofungin; Diagnosis, Differential; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Neuroaspergillosis; Neurosurgical Procedures; Pituitary Diseases; Pituitary Neoplasms; Pyrimidines; Triazoles; Voriconazole	2010
In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11 Topics: Amphotericin B; Animals; Antifungal Agents; Caspofungin; Cunninghamella; Diabetes Mellitus, Experimental; Echinocandins; Itraconazole; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Thiazoles; Triazoles; Voriconazole	2010
Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspo Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Anidulafungin; Antifungal Agents; Blood Chemical Analysis; Caspofungin; Chromatography, Liquid; Echinocandins; Humans; Itraconazole; Lipopeptides; Pyrimidines; Tandem Mass Spectrometry; Triazoles; Voriconazole	2010
Pulmonary aspergillosis in a non-neutropenic critical patient. The Journal of trauma, 2010, Volume: 69, Issue:4 Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Burns, Inhalation; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Humans; Hydrogen Sulfide; Intensive Care Units; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Respiratory Distress Syndrome; Tomography, X-Ray Computed; Triazoles; Voriconazole	2010
In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin. Chinese medical journal, 2010, Volume: 123, Issue:19 Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Echinocandins; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2010
Caspofungin plus posaconazole as salvage therapy of invasive fungal infections in immunocompromised patients. Mycoses, 2011, Volume: 54 Suppl 1 Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Retrospective Studies; Salvage Therapy; Triazoles; Young Adult	2011
In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms. Journal of Korean medical science, 2010, Volume: 25, Issue:12 Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Catheter-Related Infections; Catheterization, Central Venous; Drug Administration Routes; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2010
Antifungal susceptibility of bloodstream Candida isolates in Sfax hospital: Tunisia. Mycopathologia, 2011, Volume: 171, Issue:6 Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Lipopeptides; Male; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Triazoles; Tunisia; Voriconazole	2011
[Fatal outcome of invasive tracheal aspergillosis]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2011, Volume: 183, Issue:5 Topics: Antifungal Agents; Bronchi; Carotid Artery, External; Caspofungin; Contrast Media; Echinocandins; Fatal Outcome; Hemoptysis; Humans; Image Processing, Computer-Assisted; Iohexol; Lipopeptides; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, Spiral Computed; Trachea; Tracheal Diseases; Triazoles; Voriconazole; Young Adult	2011
Emergence of disseminated infections due to Geosmithia argillacea in patients with chronic granulomatous disease receiving long-term azole antifungal prophylaxis. Journal of clinical microbiology, 2011, Volume: 49, Issue:4 Topics: Abscess; Adolescent; Adult; Antifungal Agents; Azoles; Caspofungin; Chemoprevention; DNA, Fungal; DNA, Ribosomal Spacer; Echinocandins; Eurotiales; Fatal Outcome; Female; Granulomatous Disease, Chronic; Histocytochemistry; Humans; Interferon-gamma; Lipopeptides; Male; Microscopy; Molecular Sequence Data; Mycoses; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Triazoles	2011
Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Drug Combinations; Echinocandins; Enzyme-Linked Immunosorbent Assay; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2011
The evaluation of in vitro pharmacodynamic properties of amphotericin B, voriconazole and caspofungin against A. fumigatus isolates by the conventional and colorimetric time-kill assays. Medical mycology, 2011, Volume: 49, Issue:6 Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Tetrazolium Salts; Time Factors; Triazoles; Voriconazole	2011
In vitro effectiveness of antifungal lock solutions on catheters infected with Candida species. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:5 Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Catheter-Related Infections; Catheterization, Central Venous; Catheters, Indwelling; Colony Count, Microbial; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Triazoles	2011
Antifungal use in hospitalized adults in U.S. academic health centers. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011, Mar-01, Volume: 68, Issue:5 Topics: Academic Medical Centers; Adult; Antifungal Agents; Azoles; Caspofungin; Echinocandins; Humans; Lipopeptides; Multivariate Analysis; Practice Patterns, Physicians'; Pyrimidines; Regression Analysis; Triazoles; United States; Voriconazole	2011
Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:5 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida; Candida albicans; Caspofungin; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Plankton; Pyrimidines; Triazoles; Voriconazole	2011
Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematology; Hospital Costs; Humans; Length of Stay; Lipopeptides; Male; Middle Aged; Models, Economic; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole	2011
Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp. Journal of clinical microbiology, 2011, Volume: 49, Issue:5 Topics: Antifungal Agents; Automation; Candida; Caspofungin; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Triazoles; United States	2011
Treatment of Alternaria keratitis with intrastromal and topical caspofungin in combination with intrastromal, topical, and oral voriconazole. The Annals of pharmacotherapy, 2011, Volume: 45, Issue:5 Topics: Administration, Oral; Administration, Topical; Aged; Alternaria; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Eye Infections, Fungal; Female; Humans; Injections, Intraocular; Keratitis; Lipopeptides; Pyrimidines; Triazoles; Voriconazole	2011
Scopulariopsis brevicaulis abscess in a child treated for myeloblastic leukaemia. The Lancet. Infectious diseases, 2011, Volume: 11, Issue:5 Topics: Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Humans; Infant; Leukemia, Myeloid, Acute; Lipopeptides; Lung Abscess; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole	2011
Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis. Medical mycology, 2011, Volume: 49, Issue:8 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Colony Count, Microbial; Deoxycholic Acid; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Micafungin; Mice; Mice, Inbred DBA; Pyrimidines; Triazoles; Voriconazole	2011
Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis. Journal of clinical microbiology, 2011, Volume: 49, Issue:7 Topics: Adult; Antifungal Agents; Ascomycota; Caspofungin; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Fungemia; Heart Transplantation; Histocytochemistry; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Male; Microscopy; Molecular Sequence Data; Mycoses; Pleura; Pyrimidines; Radiography, Thoracic; Sequence Analysis, DNA; Tomography, X-Ray Computed; Triazoles; Voriconazole	2011
Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin. Medical mycology, 2012, Volume: 50, Issue:2 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Eye Infections, Fungal; Fungi; Fusarium; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
An accidental mass. Lancet (London, England), 2011, May-21, Volume: 377, Issue:9779 Topics: Accidents, Traffic; Adult; Aspergillus flavus; Caspofungin; Combined Modality Therapy; Coronary Thrombosis; Diagnosis, Differential; Disease Progression; Echinocandins; Echocardiography; Echocardiography, Transesophageal; Embolism; Emergency Service, Hospital; Endocarditis; Female; Fractures, Bone; Humans; Incidental Findings; Invasive Pulmonary Aspergillosis; Lipopeptides; Mediastinal Diseases; Pelvic Bones; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole	2011
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method. Diagnostic microbiology and infectious disease, 2011, Volume: 71, Issue:2 Topics: Antifungal Agents; Candida; Caspofungin; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2011
The reversed halo sign as the initial radiographic sign of pulmonary zygomycosis. Infection, 2012, Volume: 40, Issue:1 Topics: Amphotericin B; Antifungal Agents; Benzoates; Caspofungin; Deferasirox; Echinocandins; Fatal Outcome; Female; Humans; Iron Chelating Agents; Lipopeptides; Lung; Lung Diseases, Fungal; Middle Aged; Mucormycosis; Rhizopus; Stem Cell Transplantation; Tomography, X-Ray Computed; Triazoles	2012
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland. Mycopathologia, 2011, Volume: 172, Issue:5 Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole	2011
Selection of resistant fungi in liver transplant recipients during use of newer antifungal agents -- a report of two cases. Annals of the Academy of Medicine, Singapore, 2011, Volume: 40, Issue:6 Topics: Adult; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fluconazole; Humans; Lipopeptides; Liver Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Trichosporonosis; Voriconazole; Young Adult	2011
Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia. Infection, 2012, Volume: 40, Issue:1 Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Brain; Caspofungin; Cerebrum; Echinocandins; Humans; Larynx; Lipopeptides; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Neuroaspergillosis; Paranasal Sinuses; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Sweden; Tomography, X-Ray Computed; Triazoles; Voriconazole	2012
Fatal post-operative Trichoderma longibrachiatum mediastinitis and peritonitis in a paediatric patient with complex congenital cardiac disease on peritoneal dialysis. Journal of medical microbiology, 2011, Volume: 60, Issue:Pt 12 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child, Preschool; Echinocandins; Fatal Outcome; Female; Heart Defects, Congenital; Humans; Immunocompromised Host; Lipopeptides; Mediastinitis; Mycoses; Peritoneal Dialysis; Peritonitis; Postoperative Complications; Pyrimidines; Spleen; Triazoles; Trichoderma; Voriconazole	2011
Broth microdilution and time-kill testing of Caspofungin, voriconazole, amphotericin B and their combinations against clinical isolates of Candida krusei. Mycopathologia, 2012, Volume: 173, Issue:1 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Time Factors; Triazoles; Voriconazole	2012
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:11 Topics: Aminopyridines; Anidulafungin; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Echinocandins; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2011
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PloS one, 2011, Volume: 6, Issue:9 Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Communicable Disease Control; Cross Infection; Echinocandins; Female; Fluconazole; Hospitals; Humans; Italy; Itraconazole; Lipopeptides; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2011
Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis. Journal of clinical pathology, 2012, Volume: 65, Issue:1 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Biomarkers; Caspofungin; Disease Models, Animal; DNA, Fungal; Early Diagnosis; Echinocandins; Galactose; Immunoenzyme Techniques; Invasive Pulmonary Aspergillosis; Lipopeptides; Mannans; Microbiological Techniques; Mycological Typing Techniques; Predictive Value of Tests; Rats; Real-Time Polymerase Chain Reaction; Time Factors; Triazoles	2012
Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Diffusion Chambers, Culture; Echinocandins; Galactose; Humans; Lipopeptides; Mannans; Microbial Sensitivity Tests; Pulsatile Flow; Pyrimidines; Species Specificity; Spores, Fungal; Triazoles; Voriconazole	2012
Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1 Topics: Acylation; Aminopyridines; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Fusarium; Glycosylphosphatidylinositols; Humans; Inositol; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Triazoles; Voriconazole	2012
Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Feb-01, Volume: 54, Issue:3 Topics: Aged, 80 and over; Air Microbiology; Antifungal Agents; Aspergillosis; Aspergillus; Cardiac Surgical Procedures; Caspofungin; Coronary Care Units; Disease Outbreaks; Echinocandins; Female; Humans; Incidence; Lipopeptides; Male; Middle Aged; Pyrimidines; Spores, Fungal; Triazoles; Voriconazole	2012
[Outcome analysis of caspofungin in combination with voriconazole for treatment of 12 hematologic malignancies cases with invasive fungal infection]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2011, Volume: 32, Issue:8 Topics: Adolescent; Adult; Aged; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2011
Peptides of the constant region of antibodies display fungicidal activity. PloS one, 2012, Volume: 7, Issue:3 Topics: Animals; Antibodies; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Cryptococcus neoformans; Disease Models, Animal; Drug Resistance, Fungal; Echinocandins; Erythrocytes; Female; Hemolysis; Humans; Immunoglobulin A; Immunoglobulin Constant Regions; Immunoglobulin G; Immunoglobulin M; Lipopeptides; Malassezia; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peptides; Triazoles	2012
[Study on in vitro susceptibility of Candida spp. isolated from blood culture]. Le infezioni in medicina, 2012, Volume: 20, Issue:1 Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Risk Factors; Triazoles; Voriconazole	2012
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates. Memorias do Instituto Oswaldo Cruz, 2012, Volume: 107, Issue:3 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
[Ambulatory therapy of aspergillosis in hematological and oncological patients]. Mycoses, 2012, Volume: 55 Suppl 2 Topics: Ambulatory Care; Antifungal Agents; Caspofungin; Echinocandins; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Neutropenia; Pyrimidines; Salvage Therapy; Triazoles; Voriconazole	2012
Pseudomembranous necrotizing tracheobronchial aspergillosis: an analysis of 16 cases. Chinese medical journal, 2012, Volume: 125, Issue:7 Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Bronchoscopy; Caspofungin; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole	2012
Comparison of serum and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid-organ transplant recipients. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2012, Volume: 10, Issue:3 Topics: Adult; Antifungal Agents; Biomarkers; Bronchoalveolar Lavage Fluid; Caspofungin; Drug Therapy, Combination; Echinocandins; Galactose; Heart Transplantation; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung Transplantation; Male; Mannans; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Transplantation; Triazoles; Voriconazole	2012
Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents. The Kaohsiung journal of medical sciences, 2012, Volume: 28, Issue:6 Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
Fatal bronchial invasion of Scopulariopsis brevicaulis in an acute monocytic leukemia patient. Diagnostic microbiology and infectious disease, 2012, Volume: 73, Issue:4 Topics: Adult; Amphotericin B; Bronchi; Caspofungin; DNA, Fungal; DNA, Ribosomal; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Genes, rRNA; Histocytochemistry; Humans; Leukemia, Monocytic, Acute; Lipopeptides; Lung; Lung Diseases, Fungal; Molecular Sequence Data; Pyrimidines; Radiography, Thoracic; RNA, Fungal; RNA, Ribosomal, 18S; Scopulariopsis; Sequence Analysis, DNA; Tomography, X-Ray Computed; Treatment Failure; Triazoles; Voriconazole	2012
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis. Medical mycology, 2013, Volume: 51, Issue:2 Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Cohort Studies; Demography; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Infection Control; Length of Stay; Lipopeptides; Lung; Male; Middle Aged; Pyrimidines; Severity of Illness Index; Time Factors; Triazoles; Voriconazole	2013
Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:8 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Brain; Caspofungin; Cyclophosphamide; Deoxycholic Acid; Drug Combinations; Echinocandins; Endothelial Cells; Heart; Immunosuppression Therapy; Intercellular Adhesion Molecule-1; Kidney; Lipopeptides; Lung; Male; Mice; Nephrosis; Neuroaspergillosis; P-Selectin; Pyrimidines; Triazoles; Voriconazole	2012
Histoplasmosis in HIV-positive patients in Ceará, Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2012, Volume: 106, Issue:8 Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Caspofungin; CD4 Lymphocyte Count; Echinocandins; Female; Fluconazole; Histoplasma; Histoplasmosis; Humans; Itraconazole; L-Lactate Dehydrogenase; Lipopeptides; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates. Medical mycology, 2013, Volume: 51, Issue:1 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole	2013
[Fungal infection secondary to treatment of Escherichia coli in a critically ill patient]. Ugeskrift for laeger, 2012, Aug-27, Volume: 174, Issue:35 Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Aspergillus; Candida; Candidiasis; Caspofungin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Echinocandins; Escherichia coli; Fungemia; Humans; Lipopeptides; Male; Pyrimidines; Sepsis; Triazoles; Voriconazole	2012
In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Nitriles; Phialophora; Pyridines; Pyrimidines; Terbinafine; Triazoles; Voriconazole	2012
Prevalence and antifungal susceptibility of Candida parapsilosis complex isolates collected from oral cavities of HIV-infected individuals. Journal of medical microbiology, 2012, Volume: 61, Issue:Pt 12 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Caspofungin; Echinocandins; Female; Fluconazole; HIV Infections; Humans; Lipopeptides; Male; Microbial Sensitivity Tests; Mouth; Mycological Typing Techniques; Polymorphism, Restriction Fragment Length; Pyrimidines; Triazoles; Voriconazole	2012
Better hospital nutrition needed to prevent and treat Aspergillus infections. Medical mycology, 2013, Volume: 51, Issue:3 Topics: Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Female; Humans; Lipopeptides; Male; Pyrimidines; Triazoles; Voriconazole	2013
Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2013, Volume: 42, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Caspofungin; Colony Count, Microbial; Dentures; Diabetes Complications; Echinocandins; Female; Fluconazole; Humans; Hypertension; Kidney Failure, Chronic; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Mycology; Nystatin; Phenotype; Pyrimidines; Renal Dialysis; Time Factors; Triazoles; Voriconazole	2013
Breakthrough pulmonary Aspergillus fumigatus infection with multiple triazole resistance in a Spanish patient with chronic myeloid leukemia. Revista iberoamericana de micologia, 2013, Jan-03, Volume: 30, Issue:1 Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Caspofungin; Combined Modality Therapy; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fatal Outcome; Female; Fungal Proteins; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipopeptides; Point Mutation; Postoperative Complications; Pulmonary Aspergillosis; Recurrence; Spain; Species Specificity; Transplantation Conditioning; Transplantation, Homologous; Triazoles	2013
Interaction of the echinocandin caspofungin with amphotericin B or voriconazole against Aspergillus biofilms in vitro. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:12 Topics: Amphotericin B; Antifungal Agents; Aspergillus; Biofilms; Caspofungin; Colorimetry; Coloring Agents; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Tetrazolium Salts; Triazoles; Voriconazole	2012
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A. Annals of clinical microbiology and antimicrobials, 2012, Oct-04, Volume: 11 Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Cyclosporine; Drug Resistance, Multiple, Fungal; Drug Synergism; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Nystatin; Pyrimidines; Triazoles; Voriconazole	2012
Voriconazole stability in cement spacers. Medecine et maladies infectieuses, 2012, Volume: 42, Issue:11 Topics: Antifungal Agents; Arthroplasty, Replacement, Hip; Biofilms; Bone Cements; Candida glabrata; Candidiasis; Caspofungin; Device Removal; Dose-Response Relationship, Drug; Drug Implants; Drug Stability; Drug Therapy, Combination; Echinocandins; Hip Prosthesis; Humans; Infusions, Intravenous; Lipopeptides; Male; Middle Aged; Prostheses and Implants; Prosthesis-Related Infections; Pyrimidines; Triazoles; Voriconazole	2012
[Disseminated infection due to Geotrichum capitatum]. Medecine et maladies infectieuses, 2012, Volume: 42, Issue:11 Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Fungemia; Geotrichosis; Geotrichum; Granuloma; Hepatitis; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Lipopeptides; Male; Neutropenia; Opportunistic Infections; Sepsis; Triazoles	2012
In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis. Mycoses, 2013, Volume: 56, Issue:3 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Colistin; Cystic Fibrosis; Drug Evaluation, Preclinical; Drug Synergism; Echinocandins; Exophiala; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole	2013
Ciprofloxacin shows synergism with classical antifungals against Histoplasma capsulatum var. capsulatum and Coccidioides posadasii. Mycoses, 2013, Volume: 56, Issue:3 Topics: Antifungal Agents; Caspofungin; Ciprofloxacin; Coccidioides; Drug Evaluation, Preclinical; Drug Synergism; Echinocandins; Histoplasma; Lipopeptides; Microbial Sensitivity Tests; Mycelium; Pyrimidines; Triazoles; Voriconazole	2013
[Infectious diseases: progress in diagnosis and treatment. Topics: IV. Towards containing infectious diseases: 3. Development of new antifungal drugs]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2012, Nov-10, Volume: 101, Issue:11 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole	2012
In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:4 Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole	2013
Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilms. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:5 Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Dose-Response Relationship, Drug; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Triazoles; Voriconazole	2013
Treatment of pediatric refractory coccidioidomycosis with combination voriconazole and caspofungin: a retrospective case series. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 56, Issue:11 Topics: Adolescent; Antifungal Agents; Caspofungin; Child; Child, Preschool; Coccidioidomycosis; Echinocandins; Female; Humans; Infant; Lipopeptides; Male; Pyrimidines; Retrospective Studies; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole	2013
Elements of style in managing coccidioidomycosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 56, Issue:11 Topics: Antifungal Agents; Caspofungin; Coccidioidomycosis; Echinocandins; Female; Humans; Lipopeptides; Male; Pyrimidines; Triazoles; Voriconazole	2013
Posaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candida albicans. PloS one, 2013, Volume: 8, Issue:3 Topics: Animals; Antifungal Agents; Base Sequence; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Ergosterol; Lipopeptides; Male; Mice; Molecular Sequence Data; Mutation; Sequence Homology, Nucleic Acid; Tacrolimus; Triazoles	2013
Drug combinations against Mucor irregularis in vitro. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Combinations; Drug Synergism; Echinocandins; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mucor; Mucormycosis; Naphthalenes; Terbinafine; Triazoles	2013
[Isolation of Scedosporium apiospermum (teleomorph: Pseudallescheria apiosperma) from an acute myeloid leukemia patient]. Mikrobiyoloji bulteni, 2013, Volume: 47, Issue:2 Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Caspofungin; Echinocandins; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Lung; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole	2013
Impact of in vivo triazole and echinocandin combination therapy for invasive pulmonary aspergillosis: enhanced efficacy against Cyp51 mutant isolates. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11 Topics: Animals; Antifungal Agents; Area Under Curve; Aspergillus fumigatus; Caspofungin; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Mice; Microbial Sensitivity Tests; Spores, Fungal; Triazoles	2013
Acremonium sclerotigenum-Acremonium egyptiacum: a multi-resistant fungal pathogen complicating the course of aplastic anaemia. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20, Issue:1 Topics: Acremonium; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole	2014
Interaction between caspofungin or voriconazole and cefoperazone-sulbactam or piperacillin-tazobactam by in vitro and in vivo methods. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2014, Volume: 122, Issue:5 Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Candida albicans; Candidiasis; Caspofungin; Cefoperazone; Drug Interactions; Echinocandins; Female; Lipopeptides; Mice; Mice, Inbred BALB C; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyrimidines; Sulbactam; Triazoles; Voriconazole	2014
In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole	2013
Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients. Bone marrow transplantation, 2014, Volume: 49, Issue:1 Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fusariosis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lipopeptides; Logistic Models; Male; Mycoses; Neutrophils; Prospective Studies; Pyrimidines; Retrospective Studies; Risk; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2014
[Three cases of fungemia caused by Blastoschizomyces capitatus]. Mikrobiyoloji bulteni, 2013, Volume: 47, Issue:4 Topics: Adult; Amphotericin B; Antifungal Agents; Caspofungin; Child; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Lymphoma, B-Cell; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Saccharomycetales; Triazoles; Voriconazole; Young Adult	2013
In vitro susceptibility of Candida species to four antifungal agents assessed by the reference broth microdilution method. TheScientificWorldJournal, 2013, Volume: 2013 Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Turkey; Voriconazole	2013
Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary aspergillosis by different Aspergillus species. Mycopathologia, 2014, Volume: 177, Issue:1-2 Topics: Animals; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Caspofungin; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Galactose; Humans; Lipopeptides; Male; Mannans; Microbial Sensitivity Tests; Neutropenia; Pulmonary Aspergillosis; Pyrimidines; Rats; Rats, Sprague-Dawley; Treatment Outcome; Triazoles; Voriconazole	2014
Utilization and comparative effectiveness of caspofungin and voriconazole early after market approval in the U.S. PloS one, 2014, Volume: 9, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Caspofungin; Child; Drug Approval; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Off-Label Use; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; United States; Voriconazole; Young Adult	2014
Antibiotics sensitivity of Candida clinical and food-borne isolates. Acta biochimica Polonica, 2013, Volume: 60, Issue:4 Topics: Candida; Caspofungin; Drug Resistance, Bacterial; Echinocandins; Fluconazole; Food Microbiology; Foodborne Diseases; Humans; Lipopeptides; Nystatin; Pyrimidines; Triazoles; Voriconazole	2013
Immunomodulatory effects of voriconazole and caspofungin on human peripheral blood mononuclear cells stimulated by Candida albicans and Candida krusei. The American journal of the medical sciences, 2014, Volume: 348, Issue:3 Topics: Adult; Antifungal Agents; Candida albicans; Caspofungin; Cell Proliferation; Cells, Cultured; Echinocandins; Humans; Immunologic Factors; Leukocytes, Mononuclear; Lipopeptides; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2014
A high-definition view of endogenous fungal endophthalmitis. The Lancet. Infectious diseases, 2014, Volume: 14, Issue:4 Topics: Antifungal Agents; Caspofungin; Echinocandins; Endophthalmitis; Fundus Oculi; Humans; Lipopeptides; Male; Middle Aged; Ophthalmoscopy; Photography; Pyrimidines; Tomography, Optical Coherence; Triazoles; Voriconazole	2014
The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex. Journal of medical microbiology, 2014, Volume: 63, Issue:Pt 7 Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cyclosporine; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2014
Invasive cardiac aspergillosis after orthotopic liver transplantation. Zeitschrift fur Gastroenterologie, 2014, Volume: 52, Issue:8 Topics: Acute Disease; Caspofungin; Drug Therapy, Combination; Echinocandins; Echocardiography, Transesophageal; Hepatitis B; Humans; Lipopeptides; Liver Failure; Liver Transplantation; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Myocardium; Opportunistic Infections; Postoperative Complications; Pulmonary Aspergillosis; Triazoles	2014
Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11 Topics: Amphotericin B; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumigatus; Benzoates; Caspofungin; Deferasirox; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mucormycosis; Neutropenia; Rhizopus; Treatment Outcome; Triazoles	2014
The strength of synergistic interaction between posaconazole and caspofungin depends on the underlying azole resistance mechanism of Aspergillus fumigatus. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:3 Topics: Antifungal Agents; Aspergillus fumigatus; Azoles; Caspofungin; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fungal Proteins; Lipopeptides; Tandem Repeat Sequences; Triazoles	2015
In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs. Mycoses, 2015, Volume: 58, Issue:5 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Epidermophyton; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Nitriles; Pyridines; Terbinafine; Tinea; Triazoles; Trichophyton; Voriconazole	2015
In Vitro Triple Combination of Antifungal Drugs against Clinical Scopulariopsis and Microascus Species. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8 Topics: Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Scopulariopsis; Terbinafine; Triazoles	2015
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:9 Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole	2015
In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10 Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Genotype; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Nitriles; Pyridines; Triazoles; Voriconazole	2015
Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis. Bone marrow transplantation, 2015, Volume: 50, Issue:11 Topics: Administration, Oral; Adult; Aged; Allografts; Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Cause of Death; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Incidence; Lipopeptides; Male; Medication Adherence; Middle Aged; Mycoses; Neutropenia; Patient Compliance; Premedication; Retrospective Studies; Risk Assessment; Risk Factors; Survival Analysis; Transplantation Conditioning; Treatment Failure; Triazoles; Young Adult	2015
In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole	2015
Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses. Mycopathologia, 2016, Volume: 181, Issue:3-4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Eye; Eye Infections, Fungal; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole	2016
In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex. Mycopathologia, 2016, Volume: 181, Issue:3-4 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole	2016
In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus, an opportunistic fungal pathogen. Journal de mycologie medicale, 2016, Volume: 26, Issue:2 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Environmental Microbiology; Humans; Iran; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Opportunistic Infections; Triazoles; Voriconazole	2016
In Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus Species. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6 Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Benzoxazoles; Caspofungin; Drug Combinations; Drug Synergism; Echinocandins; Fungal Proteins; Gene Expression; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; TOR Serine-Threonine Kinases; Triazoles; Voriconazole	2016
[NEW ANTIFUNGAL DRUGS FOR PREVENTION AND TREATMENT OF VISCERAL MYCOSES]. La Revue du praticien, 2015, Volume: 65, Issue:10 Topics: Antifungal Agents; Caspofungin; Drug Therapy; Echinocandins; Humans; Lipopeptides; Micafungin; Mycoses; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole	2015
Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey. Annals of clinical microbiology and antimicrobials, 2016, May-31, Volume: 15, Issue:1 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Species Specificity; Triazoles; Voriconazole	2016
Recurrent trichosporonosis with central nervous system involvement in an allogeneic hematopoietic stem cell transplant recipient. Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:5 Topics: Anemia, Aplastic; Antibiotic Prophylaxis; Antifungal Agents; Caspofungin; Central Nervous System; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydrocephalus; Immunocompromised Host; Immunosuppression Therapy; Laminectomy; Lipopeptides; Magnetic Resonance Imaging; Opportunistic Infections; Recurrence; Transplantation, Autologous; Treatment Outcome; Triazoles; Trichosporon; Trichosporonosis; Ventriculoperitoneal Shunt; Voriconazole	2016
Tintelnotia, a new genus in Phaeosphaeriaceae harbouring agents of cornea and nail infections in humans. Mycoses, 2017, Volume: 60, Issue:4 Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Cornea; Echinocandins; Eye Infections, Fungal; Female; Humans; Itraconazole; Keratitis; Lipopeptides; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Phylogeny; Terbinafine; Triazoles; Voriconazole	2017
Epidemiological investigation of Candida species causing bloodstream infection in paediatric small bowel transplant recipients. Mycoses, 2017, Volume: 60, Issue:6 Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Female; Humans; Intestine, Small; Itraconazole; Lipopeptides; Male; Multilocus Sequence Typing; Sequence Analysis, DNA; Transplant Recipients; Triazoles; Young Adult	2017
Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans. The Journal of antimicrobial chemotherapy, 2017, 07-01, Volume: 72, Issue:7 Topics: Antifungal Agents; Ascomycota; Caspofungin; Dihydroorotate Dehydrogenase; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Oxidoreductases Acting on CH-CH Group Donors; Scedosporium; Triazoles; Voriconazole	2017
Changing epidemiology of candidaemia in Australia. The Journal of antimicrobial chemotherapy, 2017, 04-01, Volume: 72, Issue:4 Topics: Anidulafungin; Antifungal Agents; Australia; Azoles; Candida; Candida glabrata; Candida tropicalis; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole	2017
Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8 Topics: Aged; Alleles; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Azoles; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Lipopeptides; Male; Microbial Sensitivity Tests; Mutation; Treatment Outcome; Triazoles; Voriconazole	2017
Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:11 Topics: Antifungal Agents; Candida; Caspofungin; Drug Interactions; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Triazoles; Voriconazole	2017
Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates. BMC infectious diseases, 2017, 11-21, Volume: 17, Issue:1 Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cross-Sectional Studies; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Hospitals, University; Humans; Immunocompromised Host; Iran; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole	2017
Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients. Microbial pathogenesis, 2018, Volume: 115 Topics: Adolescent; Antifungal Agents; Candida; Candidiasis; Caspofungin; Child, Preschool; Echinocandins; Fluconazole; Humans; Kluyveromyces; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Nitriles; Opportunistic Infections; Pichia; Pyridines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole	2018
Liquid chromatography-tandem mass spectrometry for the quantification of moxifloxacin, ciprofloxacin, daptomycin, caspofungin, and isavuconazole in human plasma. Journal of pharmaceutical and biomedical analysis, 2018, Aug-05, Volume: 157 Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Chromatography, High Pressure Liquid; Ciprofloxacin; Daptomycin; Echinocandins; Fluoroquinolones; Humans; Limit of Detection; Lipopeptides; Moxifloxacin; Nitriles; Plasma; Pyridines; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazoles	2018
Has the Optimal Therapy for Invasive Candidiasis Now Been Defined? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 05-30, Volume: 68, Issue:12 Topics: Candida; Candidemia; Candidiasis, Invasive; Caspofungin; Humans; Nitriles; Pyridines; Triazoles	2019
Impact of Antifungal Compounds on Viability and Anti- Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:2 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Cell Survival; Deoxycholic Acid; Doxorubicin; Drug Combinations; Fluconazole; Humans; Killer Cells, Natural; Microbial Sensitivity Tests; Polyethylene Glycols; Triazoles; Voriconazole	2019
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia. Scientific reports, 2019, 03-07, Volume: 9, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult	2019
Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection. Journal of infection in developing countries, 2018, 09-30, Volume: 12, Issue:9 Topics: Adolescent; Adult; Allografts; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2018
Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp. Molecular biology reports, 2020, Volume: 47, Issue:11 Topics: Amphotericin B; Antifungal Agents; Biofilms; Caspofungin; DNA, Fungal; DNA, Ribosomal Spacer; Fluconazole; Humans; Imidazoles; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Rhodotorula; Species Specificity; Triazoles; Voriconazole	2020
In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms. Medical mycology, 2021, Oct-04, Volume: 59, Issue:10 Topics: Animals; Antifungal Agents; Biofilms; Candida; Candida auris; Caspofungin; Mice; Microbial Sensitivity Tests; Nitriles; Plankton; Pyridines; Triazoles	2021
Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran. Mycoses, 2021, Volume: 64, Issue:10 Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Coinfection; Comorbidity; COVID-19; COVID-19 Drug Treatment; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Iran; Male; Middle Aged; Mucormycosis; Respiratory Distress Syndrome; Triazoles; Young Adult	2021
Impact of antifungal stewardship interventions on the susceptibility of colonized Candida species in pediatric patients with malignancy. Scientific reports, 2021, 07-08, Volume: 11, Issue:1 Topics: Adolescent; Amphotericin B; Antifungal Agents; Antimicrobial Stewardship; Candida; Caspofungin; Child; Child, Preschool; Colony Count, Microbial; Disease Susceptibility; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Neoplasms; Triazoles	2021
Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent Antimicrobial agents and chemotherapy, 2021, 10-18, Volume: 65, Issue:11 Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Caspofungin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Kluyveromyces; Microbial Sensitivity Tests; Pichia; Saccharomycetales; Triazoles	2021
In vitro synergistic antifungal activities of caspofungin in combination with fluconazole or voriconazole against Candida species determined by the Etest method. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 122 Topics: Antifungal Agents; Candida; Candida glabrata; Caspofungin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Triazoles; Voriconazole	2022
Comparison of in vitro activities of newer triazoles and classic antifungal agents against dermatophyte species isolated from Iranian University Hospitals: a multi-central study. Annals of clinical microbiology and antimicrobials, 2023, Feb-20, Volume: 22, Issue:1 Topics: Antifungal Agents; Arthrodermataceae; Caspofungin; Fluconazole; Griseofulvin; Hospitals, University; Humans; Iran; Itraconazole; Terbinafine; Triazoles	2023